| 1 | baseline | 73,263 |
| 2 | pre-intervention | 334 |
| 3 | pretraining | 90 |
| 4 | base-line | 71 |
| 5 | lmax | 30 |
| 6 | midpregnancy | 29 |
| 7 | midtreatment | 26 |
| 8 | preoperation | 24 |
| 9 | dry-off | 19 |
| 10 | day-2 | 18 |
| 11 | end-expiration | 15 |
| 12 | intraoperation | 14 |
| 13 | pre-infusion | 13 |
| 14 | preassessment | 13 |
| 15 | 11+0 | 10 |
| 16 | 20/63 | 10 |
| 17 | midtraining | 9 |
| 18 | pre-ingestion | 9 |
| 19 | bar/restaurant | 8 |
| 20 | preinfection | 8 |
| 21 | preingestion | 8 |
| 22 | tippb | 8 |
| 23 | -178 | 7 |
| 24 | drying-off | 7 |
| 25 | tuesday | 7 |
| 26 | w16 | 7 |
| 27 | 0-week | 6 |
| 28 | kasr | 6 |
| 29 | δes | 6 |
| 30 | 1985-2004 | 5 |
| 31 | arm-level | 5 |
| 32 | cellminer | 5 |
| 33 | d13 | 5 |
| 34 | ht09 | 5 |
| 35 | l52 | 5 |
| 36 | mid-calf | 5 |
| 37 | pre-clamp | 5 |
| 38 | pre-lbnp | 5 |
| 39 | pre-transition | 5 |
| 40 | prestretching | 5 |
| 41 | rpe13 | 5 |
| 42 | scbr | 5 |
| 43 | sinaloa | 5 |
| 44 | 11:45 | 4 |
| 45 | 20g/l | 4 |
| 46 | 80/min | 4 |
| 47 | 9°c | 4 |
| 48 | adcmedian | 4 |
| 49 | errant | 4 |
| 50 | freelist | 4 |
| 51 | high-temperatures | 4 |
| 52 | jungfraujoch | 4 |
| 53 | m-pst | 4 |
| 54 | postprotocol | 4 |
| 55 | postrest | 4 |
| 56 | pre-occlusion | 4 |
| 57 | pre-ptca | 4 |
| 58 | prewash | 4 |
| 59 | wk-01 | 4 |
| 60 | xq21.3 | 4 |
| 61 | -919 | 3 |
| 62 | 05:30 | 3 |
| 63 | 1∶20 | 3 |
| 64 | 22:00-07:00 | 3 |
| 65 | 3-t. | 3 |
| 66 | 46.0°c | 3 |
| 67 | 500ng/ml | 3 |
| 68 | 50ºc | 3 |
| 69 | 6p21.1 | 3 |
| 70 | 7.3/10 | 3 |
| 71 | 9α-hy-droxy-parthenolide | 3 |
| 72 | aatsr | 3 |
| 73 | barasat | 3 |
| 74 | baseline/follow-up | 3 |
| 75 | chares | 3 |
| 76 | ego-resiliency | 3 |
| 77 | gαs | 3 |
| 78 | inkosi | 3 |
| 79 | jim | 3 |
| 80 | leucoplakia | 3 |
| 81 | luzon | 3 |
| 82 | north-america | 3 |
| 83 | p1024 | 3 |
| 84 | palref | 3 |
| 85 | pre-bi | 3 |
| 86 | pre-rehabilitative | 3 |
| 87 | pre-sbt | 3 |
| 88 | pre-work | 3 |
| 89 | rs12130333 | 3 |
| 90 | unclear/high | 3 |
| 91 | α4β2- | 3 |
| 92 | +1.1°c | 2 |
| 93 | 0.10-mmol/kg | 2 |
| 94 | 1.8+/-0.6 | 2 |
| 95 | 149/94 | 2 |
| 96 | 149°c | 2 |
| 97 | 15rm | 2 |
| 98 | 1952-2007 | 2 |
| 99 | 1971-1975 | 2 |
| 100 | 2'-azidouridine | 2 |
| 101 | 2,630.9 | 2 |
| 102 | 2-14c-acetate | 2 |
| 103 | 2-bromo-3,3,3-trifluoropropene | 2 |
| 104 | 210ma | 2 |
| 105 | 23d | 2 |
| 106 | 2th | 2 |
| 107 | 2θ | 2 |
| 108 | 3,4-diaryl-2,5-dihydrothiophenes | 2 |
| 109 | 300-700°c | 2 |
| 110 | 31.2°c | 2 |
| 111 | 35.3°c | 2 |
| 112 | 368.24 | 2 |
| 113 | 4f5/2 | 2 |
| 114 | 5metg | 2 |
| 115 | 5q35.3 | 2 |
| 116 | 6-phenyl-4- | 2 |
| 117 | 9:00am | 2 |
| 118 | acm/c1-e* | 2 |
| 119 | adherence/competence | 2 |
| 120 | agelanthus | 2 |
| 121 | argonne | 2 |
| 122 | assessment-to-assessment | 2 |
| 123 | auschwitz | 2 |
| 124 | baseline-to-post | 2 |
| 125 | basline | 2 |
| 126 | bhcel5b | 2 |
| 127 | blue/green | 2 |
| 128 | borreria | 2 |
| 129 | bucally | 2 |
| 130 | c6/7 | 2 |
| 131 | ca-fa | 2 |
| 132 | chama | 2 |
| 133 | check-lists | 2 |
| 134 | cord-csf | 2 |
| 135 | cycle-3 | 2 |
| 136 | dermatophagoidesfarina | 2 |
| 137 | dose-linearity | 2 |
| 138 | el-aghwar | 2 |
| 139 | foreplay | 2 |
| 140 | galia | 2 |
| 141 | half-scan | 2 |
| 142 | hrp/rhr | 2 |
| 143 | huntsville | 2 |
| 144 | kir3 | 2 |
| 145 | medawachchiya | 2 |
| 146 | ms4a4e | 2 |
| 147 | near-conscious | 2 |
| 148 | paraphenylenediamine | 2 |
| 149 | photocopiers | 2 |
| 150 | picrasma | 2 |
| 151 | pre-delirium | 2 |
| 152 | pre-pbmv | 2 |
| 153 | pre-qin | 2 |
| 154 | prenitroglycerin | 2 |
| 155 | presitting | 2 |
| 156 | s83i | 2 |
| 157 | ser-367 | 2 |
| 158 | ser33/37 | 2 |
| 159 | ser69 | 2 |
| 160 | sinikithemba | 2 |
| 161 | t5-t8 | 2 |
| 162 | t6h | 2 |
| 163 | tex4 | 2 |
| 164 | thermo-sensitisation | 2 |
| 165 | thielaviopsis | 2 |
| 166 | tpf-ccrt | 2 |
| 167 | trinitrophenylated | 2 |
| 168 | ufr-mdm | 2 |
| 169 | weifang | 2 |
| 170 | 'episodic | 1 |
| 171 | -1°c/min | 1 |
| 172 | -2.44±1.00d | 1 |
| 173 | -48.3±1.5mpa | 1 |
| 174 | -5.68°/s | 1 |
| 175 | -6.04°/s | 1 |
| 176 | -chloro | 1 |
| 177 | 0,2,3 | 1 |
| 178 | 0,2,4,6,8 | 1 |
| 179 | 0-1793 | 1 |
| 180 | 0.1687 | 1 |
| 181 | 0.2167 | 1 |
| 182 | 0.25±0.56 | 1 |
| 183 | 0.35-2.04μm | 1 |
| 184 | 0.44±0.46 | 1 |
| 185 | 0.4ngg | 1 |
| 186 | 0.53+/-0.09 | 1 |
| 187 | 0.58/1000 | 1 |
| 188 | 0.59±0.38days | 1 |
| 189 | 0.6-1mg/ml | 1 |
| 190 | 0.61×10 | 1 |
| 191 | 0.6x10 | 1 |
| 192 | 0.71±0.11 | 1 |
| 193 | 0.8-24 | 1 |
| 194 | 0.80mm | 1 |
| 195 | 0.89±1.03 | 1 |
| 196 | 0.8:0.2 | 1 |
| 197 | 0.9gl | 1 |
| 198 | 05.03.2012 | 1 |
| 199 | 07:00-h | 1 |
| 200 | 0hpf | 1 |
| 201 | 1,2,4,8 | 1 |
| 202 | 1,4-enediones | 1 |
| 203 | 1-119 | 1 |
| 204 | 1-256 | 1 |
| 205 | 1-copper | 1 |
| 206 | 1.04-1.05 | 1 |
| 207 | 1.19-2.64 | 1 |
| 208 | 1.6-10.5 | 1 |
| 209 | 1.7690 | 1 |
| 210 | 1.80å | 1 |
| 211 | 1/1/99-12/31/00 | 1 |
| 212 | 10,000×g | 1 |
| 213 | 10-50μm | 1 |
| 214 | 101.325 | 1 |
| 215 | 101/111 | 1 |
| 216 | 108.108 | 1 |
| 217 | 10np | 1 |
| 218 | 11-bromoundecan-1-ol | 1 |
| 219 | 1146±182 | 1 |
| 220 | 118/240 | 1 |
| 221 | 11pg/ml | 1 |
| 222 | 11μmol/l | 1 |
| 223 | 12,24,36 | 1 |
| 224 | 12.32+/-4.35 | 1 |
| 225 | 12.5-356 | 1 |
| 226 | 121/7 | 1 |
| 227 | 1250-1254 | 1 |
| 228 | 128.4±22.1 | 1 |
| 229 | 1360±920iu/g | 1 |
| 230 | 14,866 | 1 |
| 231 | 14.2kgs | 1 |
| 232 | 14.6+/-4.6 | 1 |
| 233 | 140kv | 1 |
| 234 | 142.34 | 1 |
| 235 | 142μg/ml | 1 |
| 236 | 143.98 | 1 |
| 237 | 145.4/80.1 | 1 |
| 238 | 15-37°c | 1 |
| 239 | 15.2±0.3 | 1 |
| 240 | 157/93 | 1 |
| 241 | 164.1±33.1 | 1 |
| 242 | 166.4/85.8 | 1 |
| 243 | 17.93±1.84 | 1 |
| 244 | 17qter | 1 |
| 245 | 18.2μmol/l | 1 |
| 246 | 18.8-24.1/11.7-15.5 | 1 |
| 247 | 183.95 | 1 |
| 248 | 183±44 | 1 |
| 249 | 189.35 | 1 |
| 250 | 19,613 | 1 |
| 251 | 191/220 | 1 |
| 252 | 193/218 | 1 |
| 253 | 1940-2009 | 1 |
| 254 | 1946-present | 1 |
| 255 | 1947-54 | 1 |
| 256 | 1956-1991 | 1 |
| 257 | 1958-1967 | 1 |
| 258 | 1959-67 | 1 |
| 259 | 1966-onwards | 1 |
| 260 | 1969-1983 | 1 |
| 261 | 1974-90 | 1 |
| 262 | 1978-2006 | 1 |
| 263 | 1995-2013 | 1 |
| 264 | 1997-2005.subjects | 1 |
| 265 | 1a-1k | 1 |
| 266 | 1·075 | 1 |
| 267 | 2,2-dimethyl-1,3-diaminopropan | 1 |
| 268 | 2,3,4,6-tetrabenzylglucose | 1 |
| 269 | 2,3,5,4'-tetrahydroxystilbene-2-o-β-glucoside | 1 |
| 270 | 2-amino-nicotinonitrile | 1 |
| 271 | 2-chloro-1,3,5-trinitrobenzene | 1 |
| 272 | 2-chloronicotinaldehydes | 1 |
| 273 | 2-cyanoguanidine | 1 |
| 274 | 2-ethynylanilines | 1 |
| 275 | 2-ethynylbiaryls | 1 |
| 276 | 2-oxo-n'- | 1 |
| 277 | 2-oxo-quinoline-3-carbaldehyde | 1 |
| 278 | 2.09±0.55 | 1 |
| 279 | 2.0μg/day | 1 |
| 280 | 2.13×10 | 1 |
| 281 | 2.3667 | 1 |
| 282 | 2.5-hz | 1 |
| 283 | 2.5-month | 1 |
| 284 | 2.50±0.33kg | 1 |
| 285 | 2.51-26.7 | 1 |
| 286 | 2.7826 | 1 |
| 287 | 2.8390 | 1 |
| 288 | 2.9255 | 1 |
| 289 | 20.6ml/min/1.73m | 1 |
| 290 | 2004-11 | 1 |
| 291 | 2007-06/2008 | 1 |
| 292 | 214° | 1 |
| 293 | 218.33 | 1 |
| 294 | 218.3ucarr | 1 |
| 295 | 22.9kj/m | 1 |
| 296 | 22.9°c | 1 |
| 297 | 22˚c | 1 |
| 298 | 23,147.3 | 1 |
| 299 | 23.9+/-9 | 1 |
| 300 | 233+/-156 | 1 |
| 301 | 24,885 | 1 |
| 302 | 2465.97 | 1 |
| 303 | 246k | 1 |
| 304 | 24min | 1 |
| 305 | 25-67°c | 1 |
| 306 | 25.3+/-2.5 | 1 |
| 307 | 26,168 | 1 |
| 308 | 26.1±1.7 | 1 |
| 309 | 264.16 | 1 |
| 310 | 269/440 | 1 |
| 311 | 27.2-66 | 1 |
| 312 | 273.17 | 1 |
| 313 | 2758+/-197 | 1 |
| 314 | 28,881 | 1 |
| 315 | 3'-c-methyladenosine | 1 |
| 316 | 3+/5 | 1 |
| 317 | 3,6,9 | 1 |
| 318 | 3-benzoylpyridazines | 1 |
| 319 | 3-bromo-n- | 1 |
| 320 | 3-bromoquinolin-2 | 1 |
| 321 | 3-c-methyl-d-allose | 1 |
| 322 | 3-dimension-al | 1 |
| 323 | 3-mercaptohexanol | 1 |
| 324 | 3-methylpiperidine | 1 |
| 325 | 3-o-methylated- | 1 |
| 326 | 3-wp/fac | 1 |
| 327 | 3.0-t. | 1 |
| 328 | 3.3714 | 1 |
| 329 | 30,60,120 | 1 |
| 330 | 30.1-35.5°c | 1 |
| 331 | 300mmhg | 1 |
| 332 | 300mpa | 1 |
| 333 | 31,000/mm | 1 |
| 334 | 31-102 | 1 |
| 335 | 31.25μg/ml | 1 |
| 336 | 324/339 | 1 |
| 337 | 32pg/ml | 1 |
| 338 | 35.6°c | 1 |
| 339 | 350mg/dl | 1 |
| 340 | 355.56 | 1 |
| 341 | 36.0-89.4 | 1 |
| 342 | 36/30°c | 1 |
| 343 | 37.0/100 | 1 |
| 344 | 385±28 | 1 |
| 345 | 390000 | 1 |
| 346 | 393/519 | 1 |
| 347 | 398/656 | 1 |
| 348 | 3´-azido-3´-deoxythymidine | 1 |
| 349 | 4,8,12,16,26 | 1 |
| 350 | 4-amino-6-methyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5 | 1 |
| 351 | 4-bromo-2-methoxyphenol | 1 |
| 352 | 4-hydroperoxy-2-nonenal | 1 |
| 353 | 4-methoxyaniline | 1 |
| 354 | 4-methylbenzaldehyde | 1 |
| 355 | 4.3×10 | 1 |
| 356 | 40-60°c | 1 |
| 357 | 43.5°c | 1 |
| 358 | 43.7±13.2iu/g | 1 |
| 359 | 45°-60° | 1 |
| 360 | 46-1,662 | 1 |
| 361 | 46±3 | 1 |
| 362 | 48+/-4 | 1 |
| 363 | 490/603 | 1 |
| 364 | 4·04-2·88 | 1 |
| 365 | 5,806 | 1 |
| 366 | 5-acetyl-4-hydroxy-2h-1,3-thiazine-2,6 | 1 |
| 367 | 5-ethynylthiophene-2-sulfonamide | 1 |
| 368 | 5.2+/-3.8 | 1 |
| 369 | 5.29±2.3 | 1 |
| 370 | 5.8+/-0.049 | 1 |
| 371 | 50-60-70-80 | 1 |
| 372 | 51.1/10 | 1 |
| 373 | 525°c | 1 |
| 374 | 53.5microm/l | 1 |
| 375 | 544.06 | 1 |
| 376 | 58/81 | 1 |
| 377 | 5:4:13 | 1 |
| 378 | 5p15.2pter | 1 |
| 379 | 6,12,18,24 | 1 |
| 380 | 6,249 | 1 |
| 381 | 6,600/mm | 1 |
| 382 | 6-acetyl-1,3,7-trimethyllumazine | 1 |
| 383 | 6-deoxy-d-glucal | 1 |
| 384 | 6-trifluoromethylpyridine-2 | 1 |
| 385 | 6.3kj/m | 1 |
| 386 | 6.7+/-0.83 | 1 |
| 387 | 681studies | 1 |
| 388 | 690nm | 1 |
| 389 | 699.3 | 1 |
| 390 | 6th-graders | 1 |
| 391 | 7,476 | 1 |
| 392 | 7-38°c | 1 |
| 393 | 7-hydroxy-4-methylcoumarin | 1 |
| 394 | 7.1×10 | 1 |
| 395 | 7.87±8.14 | 1 |
| 396 | 700k | 1 |
| 397 | 700ºc | 1 |
| 398 | 72.0+/-11.4 | 1 |
| 399 | 730nm | 1 |
| 400 | 7567 | 1 |
| 401 | 798+/-13 | 1 |
| 402 | 7mpa | 1 |
| 403 | 8,275 | 1 |
| 404 | 8.00am | 1 |
| 405 | 8.2911 | 1 |
| 406 | 8.2±1.7j/m | 1 |
| 407 | 8.2±3.0 | 1 |
| 408 | 8.4557 | 1 |
| 409 | 8.62±9.85 | 1 |
| 410 | 801.8 | 1 |
| 411 | 8013€ | 1 |
| 412 | 81.8±25.2 | 1 |
| 413 | 813±62 | 1 |
| 414 | 82-587 | 1 |
| 415 | 883.4 | 1 |
| 416 | 8pter | 1 |
| 417 | 9.0±20.8 | 1 |
| 418 | 9.3-63 | 1 |
| 419 | 9.3pg/ml | 1 |
| 420 | 90.42 | 1 |
| 421 | 98-110 | 1 |
| 422 | 996·7 | 1 |
| 423 | 9:4:7:6 | 1 |
| 424 | a752 | 1 |
| 425 | aaipharma | 1 |
| 426 | abiotrophia | 1 |
| 427 | acandí | 1 |
| 428 | aceptable | 1 |
| 429 | acetoacetanilide | 1 |
| 430 | acm/c3-aj | 1 |
| 431 | actn3-knockout | 1 |
| 432 | advanced-age | 1 |
| 433 | advancent | 1 |
| 434 | ag525 | 1 |
| 435 | agarose-overlaid | 1 |
| 436 | ages‑induced | 1 |
| 437 | aidsinfo | 1 |
| 438 | alpha3beta3gamma2 | 1 |
| 439 | amia | 1 |
| 440 | androst-4-en-3,17-dione | 1 |
| 441 | another-and | 1 |
| 442 | antiinitiation | 1 |
| 443 | aquidauana | 1 |
| 444 | arbatax | 1 |
| 445 | arg45 | 1 |
| 446 | arterio-to-mixed-venous | 1 |
| 447 | arylsulfonamides | 1 |
| 448 | asn27 | 1 |
| 449 | assobiomedica | 1 |
| 450 | atmospheric/soil | 1 |
| 451 | autoanti-di | 1 |
| 452 | baicheng | 1 |
| 453 | baseleine | 1 |
| 454 | baseline,1 | 1 |
| 455 | baseline-overload | 1 |
| 456 | baseline-posttreatment | 1 |
| 457 | baseline.due | 1 |
| 458 | baseline/randomization | 1 |
| 459 | baseline=8.9 | 1 |
| 460 | batna | 1 |
| 461 | beijng | 1 |
| 462 | bhagirathi | 1 |
| 463 | bird-head | 1 |
| 464 | bis-methylene | 1 |
| 465 | bl-d7 | 1 |
| 466 | blank- | 1 |
| 467 | boc-tyr-pro-oh | 1 |
| 468 | bolu | 1 |
| 469 | bothvb1 | 1 |
| 470 | bott | 1 |
| 471 | breast/ovarian- | 1 |
| 472 | bush-doctors | 1 |
| 473 | c25 | 1 |
| 474 | c38 | 1 |
| 475 | c4c5 | 1 |
| 476 | c57bl/6-tg | 1 |
| 477 | c646 | 1 |
| 478 | c6c7 | 1 |
| 479 | campanian-maastrichtian | 1 |
| 480 | caprines | 1 |
| 481 | carboxyhaemoglobinaemia | 1 |
| 482 | cardio2000 | 1 |
| 483 | case-database | 1 |
| 484 | cause- | 1 |
| 485 | cbma | 1 |
| 486 | cetingrad | 1 |
| 487 | chendring | 1 |
| 488 | chinnallapuram | 1 |
| 489 | chloromethylmethoxypsoralen | 1 |
| 490 | choma | 1 |
| 491 | chondroitin-4-sulfate | 1 |
| 492 | chuk1 | 1 |
| 493 | clc-3-/- | 1 |
| 494 | clofibrinic | 1 |
| 495 | close-to-optimal | 1 |
| 496 | cobolt-60 | 1 |
| 497 | codont | 1 |
| 498 | colposcopic/bioptic | 1 |
| 499 | cona-activated | 1 |
| 500 | conciliation | 1 |
| 501 | core-foods | 1 |
| 502 | cox5-6 | 1 |
| 503 | coxalgia | 1 |
| 504 | cpap10 | 1 |
| 505 | cran | 1 |
| 506 | cross-purposes | 1 |
| 507 | cueva | 1 |
| 508 | cuso4•5h2o | 1 |
| 509 | cv23 | 1 |
| 510 | c₄₀₋₆₄ | 1 |
| 511 | d.e.s.i.r. | 1 |
| 512 | d01 | 1 |
| 513 | database-deposited | 1 |
| 514 | daybreak | 1 |
| 515 | dbgap | 1 |
| 516 | deoxyuridylate | 1 |
| 517 | diagnosis-injection | 1 |
| 518 | dimethyphtalate | 1 |
| 519 | discharge-bun | 1 |
| 520 | doctors/hospitals | 1 |
| 521 | doddaballapur | 1 |
| 522 | dry/nonproductive | 1 |
| 523 | duhok | 1 |
| 524 | dunavant | 1 |
| 525 | dyspnoes | 1 |
| 526 | e11.5-12.5 | 1 |
| 527 | e11.5-15.5 | 1 |
| 528 | e9.5-12.5 | 1 |
| 529 | echo-pressure | 1 |
| 530 | echo-tracked | 1 |
| 531 | egfr-treated | 1 |
| 532 | eml2 | 1 |
| 533 | end-of-core | 1 |
| 534 | end-of-diastole | 1 |
| 535 | endocrinometabolic | 1 |
| 536 | epikur | 1 |
| 537 | eses-treatment | 1 |
| 538 | eucosterol | 1 |
| 539 | euro226.57 | 1 |
| 540 | f127/hpmc | 1 |
| 541 | ferrell | 1 |
| 542 | ferrous/ferric- | 1 |
| 543 | fish-miso | 1 |
| 544 | freetest.me | 1 |
| 545 | fty720-treated | 1 |
| 546 | fundhacre | 1 |
| 547 | g1-g5 | 1 |
| 548 | g3b | 1 |
| 549 | gainp | 1 |
| 550 | gaoliang | 1 |
| 551 | germline-enriched | 1 |
| 552 | gln16 | 1 |
| 553 | gongzhuling | 1 |
| 554 | grimmen | 1 |
| 555 | gynecologists/urogynecologists | 1 |
| 556 | gynecomastias | 1 |
| 557 | görlitz | 1 |
| 558 | hansatech | 1 |
| 559 | haughty | 1 |
| 560 | hemimorphite | 1 |
| 561 | hexa-ni | 1 |
| 562 | hexian | 1 |
| 563 | hfc-245fa | 1 |
| 564 | hif-inhibitors | 1 |
| 565 | high-enough | 1 |
| 566 | higher-titer | 1 |
| 567 | hiv-acquisition | 1 |
| 568 | holo-protein | 1 |
| 569 | hospital-ward | 1 |
| 570 | hospital.5 | 1 |
| 571 | hospital/regional | 1 |
| 572 | hospitalizedpatients | 1 |
| 573 | hyptonia | 1 |
| 574 | igane | 1 |
| 575 | il-27r | 1 |
| 576 | in-stent-restenosis | 1 |
| 577 | inositol-p-ceramide | 1 |
| 578 | intergeneric | 1 |
| 579 | intra-f | 1 |
| 580 | ipl/tssc3/bwr1c | 1 |
| 581 | ir-exposed | 1 |
| 582 | isla | 1 |
| 583 | isoosmolality | 1 |
| 584 | italian- | 1 |
| 585 | jangseong | 1 |
| 586 | jeotgal | 1 |
| 587 | jiaxing | 1 |
| 588 | k-puszta | 1 |
| 589 | kloppe | 1 |
| 590 | kmgf3 | 1 |
| 591 | kwok | 1 |
| 592 | l3-s1 | 1 |
| 593 | lankaran | 1 |
| 594 | lappro | 1 |
| 595 | lc-ωpbe | 1 |
| 596 | ldl-precursors | 1 |
| 597 | left-censored | 1 |
| 598 | li2c2o5 | 1 |
| 599 | live-online | 1 |
| 600 | log-normality | 1 |
| 601 | louata | 1 |
| 602 | low/highly-perturbed | 1 |
| 603 | lvov | 1 |
| 604 | mainling | 1 |
| 605 | malay-balay | 1 |
| 606 | maljen | 1 |
| 607 | mcpa | 1 |
| 608 | me2culi⋅lisph | 1 |
| 609 | meat- | 1 |
| 610 | mendota | 1 |
| 611 | merck-medco | 1 |
| 612 | mesolithic | 1 |
| 613 | metformin/sulfonylureas | 1 |
| 614 | methimazole- | 1 |
| 615 | methoxy-poly | 1 |
| 616 | metzner | 1 |
| 617 | mex-5/6 | 1 |
| 618 | micro-ulcers | 1 |
| 619 | mid-duodenum | 1 |
| 620 | mid-tens | 1 |
| 621 | mithocondria | 1 |
| 622 | mixed-occupied | 1 |
| 623 | mn3sn | 1 |
| 624 | mock- | 1 |
| 625 | moct1/2 | 1 |
| 626 | moet- | 1 |
| 627 | mogadishu | 1 |
| 628 | mongu | 1 |
| 629 | mononitrotetrakis | 1 |
| 630 | moravek | 1 |
| 631 | motuo | 1 |
| 632 | mp2/aug-cc-pvdz | 1 |
| 633 | msh4 | 1 |
| 634 | mutated-type | 1 |
| 635 | n-alkyl- | 1 |
| 636 | n-bn | 1 |
| 637 | naprp | 1 |
| 638 | narezushi | 1 |
| 639 | nawarangapur | 1 |
| 640 | nct01008033 | 1 |
| 641 | ndirande | 1 |
| 642 | nicotine/cotinine/3-oh-cot | 1 |
| 643 | nigerien | 1 |
| 644 | ninhydrine | 1 |
| 645 | non-achd | 1 |
| 646 | non-mtrps | 1 |
| 647 | nonhealers | 1 |
| 648 | nontransamidated | 1 |
| 649 | normoleptinemic | 1 |
| 650 | nuts-1 | 1 |
| 651 | nyanga | 1 |
| 652 | nyingchi | 1 |
| 653 | o-alkynyl-n | 1 |
| 654 | o-vinylbenzaldehyde | 1 |
| 655 | okpanku | 1 |
| 656 | oncoantigens | 1 |
| 657 | over-regulation | 1 |
| 658 | over-stress | 1 |
| 659 | ozonytronx | 1 |
| 660 | p-nitrotoluene | 1 |
| 661 | p550 | 1 |
| 662 | p73-deficient | 1 |
| 663 | palencia | 1 |
| 664 | pardis | 1 |
| 665 | parthenin | 1 |
| 666 | participants.weight-for-age | 1 |
| 667 | pbd4 | 1 |
| 668 | peracarida | 1 |
| 669 | peridiverticulitis | 1 |
| 670 | ph.d.p. | 1 |
| 671 | ph=6 | 1 |
| 672 | phanerobranchia | 1 |
| 673 | ph≥7 | 1 |
| 674 | pikas | 1 |
| 675 | pinane- | 1 |
| 676 | pn21 | 1 |
| 677 | population-recruited | 1 |
| 678 | post-first-injection | 1 |
| 679 | post-immediately | 1 |
| 680 | post-trascriptional | 1 |
| 681 | pound4,261 | 1 |
| 682 | power-from-within | 1 |
| 683 | pre-apprentices | 1 |
| 684 | pre-blooming | 1 |
| 685 | pre-bpv | 1 |
| 686 | pre-immigration | 1 |
| 687 | pre-pace | 1 |
| 688 | pre-to-posttreatment | 1 |
| 689 | prenosological | 1 |
| 690 | preoxygenator | 1 |
| 691 | preproenkephalin | 1 |
| 692 | preruminants | 1 |
| 693 | pressure-volume-temperature | 1 |
| 694 | pretreatmer | 1 |
| 695 | privately- | 1 |
| 696 | pro-tk-subtilisin | 1 |
| 697 | providers/clinics | 1 |
| 698 | pseudokeratosis | 1 |
| 699 | p≤0·025 | 1 |
| 700 | q312 | 1 |
| 701 | queenscliff | 1 |
| 702 | r-30 | 1 |
| 703 | radio-meter | 1 |
| 704 | radon-222 | 1 |
| 705 | regional/tertiary | 1 |
| 706 | regshospitalet | 1 |
| 707 | remitted-recurrent | 1 |
| 708 | rerevascularization | 1 |
| 709 | rest/cough | 1 |
| 710 | rest/lvef | 1 |
| 711 | rest/postprandial/during | 1 |
| 712 | rhic | 1 |
| 713 | riks-stroke | 1 |
| 714 | rs1685354 | 1 |
| 715 | s2481 | 1 |
| 716 | sagae-shi | 1 |
| 717 | sbm-bound | 1 |
| 718 | scadding | 1 |
| 719 | self-preoccupation | 1 |
| 720 | ser-54 | 1 |
| 721 | ser-587 | 1 |
| 722 | ser385 | 1 |
| 723 | ser635 | 1 |
| 724 | serine473 | 1 |
| 725 | serologist | 1 |
| 726 | service-entry | 1 |
| 727 | sesuvium | 1 |
| 728 | sf36-fd | 1 |
| 729 | shillong | 1 |
| 730 | short-gap | 1 |
| 731 | sleep/attention | 1 |
| 732 | small-arteries | 1 |
| 733 | small-trials | 1 |
| 734 | sogn | 1 |
| 735 | sopungsunkiwon | 1 |
| 736 | speech-act | 1 |
| 737 | st18 | 1 |
| 738 | state-to-state | 1 |
| 739 | stimulator- | 1 |
| 740 | subbloom | 1 |
| 741 | subpasteurization | 1 |
| 742 | suihua | 1 |
| 743 | swespine | 1 |
| 744 | symptoms/events | 1 |
| 745 | t11-12 | 1 |
| 746 | t12/l1 | 1 |
| 747 | t5· | 1 |
| 748 | t=20 | 1 |
| 749 | terena | 1 |
| 750 | tetrapak | 1 |
| 751 | th4-th5 | 1 |
| 752 | the-medical | 1 |
| 753 | thermonuetral | 1 |
| 754 | thr-696 | 1 |
| 755 | three-randomized | 1 |
| 756 | threonine-181 | 1 |
| 757 | tms- | 1 |
| 758 | tmz/rt | 1 |
| 759 | topographic- | 1 |
| 760 | torremolinos | 1 |
| 761 | trackvis | 1 |
| 762 | trans-2-aroyl-3-aryl-cyclopropane-1,1-dicarboxylates | 1 |
| 763 | trans-gauche | 1 |
| 764 | tributed | 1 |
| 765 | trimpark | 1 |
| 766 | trisaturated | 1 |
| 767 | trnaglu-trnaphe | 1 |
| 768 | trois-rivières | 1 |
| 769 | trøndelag | 1 |
| 770 | turn-out | 1 |
| 771 | u121 | 1 |
| 772 | ulcer/erosion | 1 |
| 773 | unpopularity | 1 |
| 774 | usd791 | 1 |
| 775 | uti-infants | 1 |
| 776 | varibench | 1 |
| 777 | vero- | 1 |
| 778 | vince | 1 |
| 779 | viups | 1 |
| 780 | vo2net | 1 |
| 781 | walk-around | 1 |
| 782 | warfarin-elevated | 1 |
| 783 | webthal® | 1 |
| 784 | weeks-4 | 1 |
| 785 | whangapoua | 1 |
| 786 | whccs | 1 |
| 787 | workshop-floors | 1 |
| 788 | wuzhou | 1 |
| 789 | www.cri-net.com | 1 |
| 790 | x=0.3 | 1 |
| 791 | xianyang | 1 |
| 792 | xionghuang | 1 |
| 793 | xocotitla | 1 |
| 794 | yang-meridian | 1 |
| 795 | years-5 | 1 |
| 796 | yongding | 1 |
| 797 | youtube.com | 1 |
| 798 | yuanlijian | 1 |
| 799 | £13,290 | 1 |
| 800 | £3002/patient | 1 |
| 801 | £3855/qaly | 1 |
| 802 | α-napthylamine | 1 |
| 803 | α-silyl- | 1 |
| 804 | α-trifluoromethyl-α | 1 |
| 805 | α4β4- | 1 |
| 806 | αs- | 1 |
| 807 | δmg/cm2/min/°c | 1 |
| 808 | δmyoglobin | 1 |
| 809 | €2430 | 1 |
| 810 | €3011/qaly | 1 |
| 811 | €33,500 | 1 |
| 812 | €6520 | 1 |
| 813 | €788 | 1 |
| 814 | €8000/qaly | 1 |
| 815 | ∼240 | 1 |
| 816 | ∼404 | 1 |
| 817 | ∼688 | 1 |
| 1 | 'episodic | 1 |
| 2 | +1.1°c | 2 |
| 3 | -178 | 7 |
| 4 | -1°c/min | 1 |
| 5 | -2.44±1.00d | 1 |
| 6 | -48.3±1.5mpa | 1 |
| 7 | -5.68°/s | 1 |
| 8 | -6.04°/s | 1 |
| 9 | -919 | 3 |
| 10 | -chloro | 1 |
| 11 | 0,2,3 | 1 |
| 12 | 0,2,4,6,8 | 1 |
| 13 | 0-1793 | 1 |
| 14 | 0-week | 6 |
| 15 | 0.10-mmol/kg | 2 |
| 16 | 0.1687 | 1 |
| 17 | 0.2167 | 1 |
| 18 | 0.25±0.56 | 1 |
| 19 | 0.35-2.04μm | 1 |
| 20 | 0.44±0.46 | 1 |
| 21 | 0.4ngg | 1 |
| 22 | 0.53+/-0.09 | 1 |
| 23 | 0.58/1000 | 1 |
| 24 | 0.59±0.38days | 1 |
| 25 | 0.6-1mg/ml | 1 |
| 26 | 0.61×10 | 1 |
| 27 | 0.6x10 | 1 |
| 28 | 0.71±0.11 | 1 |
| 29 | 0.8-24 | 1 |
| 30 | 0.80mm | 1 |
| 31 | 0.89±1.03 | 1 |
| 32 | 0.8:0.2 | 1 |
| 33 | 0.9gl | 1 |
| 34 | 05.03.2012 | 1 |
| 35 | 05:30 | 3 |
| 36 | 07:00-h | 1 |
| 37 | 0hpf | 1 |
| 38 | 1,2,4,8 | 1 |
| 39 | 1,4-enediones | 1 |
| 40 | 1-119 | 1 |
| 41 | 1-256 | 1 |
| 42 | 1-copper | 1 |
| 43 | 1.04-1.05 | 1 |
| 44 | 1.19-2.64 | 1 |
| 45 | 1.6-10.5 | 1 |
| 46 | 1.7690 | 1 |
| 47 | 1.8+/-0.6 | 2 |
| 48 | 1.80å | 1 |
| 49 | 1/1/99-12/31/00 | 1 |
| 50 | 10,000×g | 1 |
| 51 | 10-50μm | 1 |
| 52 | 101.325 | 1 |
| 53 | 101/111 | 1 |
| 54 | 108.108 | 1 |
| 55 | 10np | 1 |
| 56 | 11+0 | 10 |
| 57 | 11-bromoundecan-1-ol | 1 |
| 58 | 1146±182 | 1 |
| 59 | 118/240 | 1 |
| 60 | 11:45 | 4 |
| 61 | 11pg/ml | 1 |
| 62 | 11μmol/l | 1 |
| 63 | 12,24,36 | 1 |
| 64 | 12.32+/-4.35 | 1 |
| 65 | 12.5-356 | 1 |
| 66 | 121/7 | 1 |
| 67 | 1250-1254 | 1 |
| 68 | 128.4±22.1 | 1 |
| 69 | 1360±920iu/g | 1 |
| 70 | 14,866 | 1 |
| 71 | 14.2kgs | 1 |
| 72 | 14.6+/-4.6 | 1 |
| 73 | 140kv | 1 |
| 74 | 142.34 | 1 |
| 75 | 142μg/ml | 1 |
| 76 | 143.98 | 1 |
| 77 | 145.4/80.1 | 1 |
| 78 | 149/94 | 2 |
| 79 | 149°c | 2 |
| 80 | 15-37°c | 1 |
| 81 | 15.2±0.3 | 1 |
| 82 | 157/93 | 1 |
| 83 | 15rm | 2 |
| 84 | 164.1±33.1 | 1 |
| 85 | 166.4/85.8 | 1 |
| 86 | 17.93±1.84 | 1 |
| 87 | 17qter | 1 |
| 88 | 18.2μmol/l | 1 |
| 89 | 18.8-24.1/11.7-15.5 | 1 |
| 90 | 183.95 | 1 |
| 91 | 183±44 | 1 |
| 92 | 189.35 | 1 |
| 93 | 19,613 | 1 |
| 94 | 191/220 | 1 |
| 95 | 193/218 | 1 |
| 96 | 1940-2009 | 1 |
| 97 | 1946-present | 1 |
| 98 | 1947-54 | 1 |
| 99 | 1952-2007 | 2 |
| 100 | 1956-1991 | 1 |
| 101 | 1958-1967 | 1 |
| 102 | 1959-67 | 1 |
| 103 | 1966-onwards | 1 |
| 104 | 1969-1983 | 1 |
| 105 | 1971-1975 | 2 |
| 106 | 1974-90 | 1 |
| 107 | 1978-2006 | 1 |
| 108 | 1985-2004 | 5 |
| 109 | 1995-2013 | 1 |
| 110 | 1997-2005.subjects | 1 |
| 111 | 1a-1k | 1 |
| 112 | 1·075 | 1 |
| 113 | 1∶20 | 3 |
| 114 | 2'-azidouridine | 2 |
| 115 | 2,2-dimethyl-1,3-diaminopropan | 1 |
| 116 | 2,3,4,6-tetrabenzylglucose | 1 |
| 117 | 2,3,5,4'-tetrahydroxystilbene-2-o-β-glucoside | 1 |
| 118 | 2,630.9 | 2 |
| 119 | 2-14c-acetate | 2 |
| 120 | 2-amino-nicotinonitrile | 1 |
| 121 | 2-bromo-3,3,3-trifluoropropene | 2 |
| 122 | 2-chloro-1,3,5-trinitrobenzene | 1 |
| 123 | 2-chloronicotinaldehydes | 1 |
| 124 | 2-cyanoguanidine | 1 |
| 125 | 2-ethynylanilines | 1 |
| 126 | 2-ethynylbiaryls | 1 |
| 127 | 2-oxo-n'- | 1 |
| 128 | 2-oxo-quinoline-3-carbaldehyde | 1 |
| 129 | 2.09±0.55 | 1 |
| 130 | 2.0μg/day | 1 |
| 131 | 2.13×10 | 1 |
| 132 | 2.3667 | 1 |
| 133 | 2.5-hz | 1 |
| 134 | 2.5-month | 1 |
| 135 | 2.50±0.33kg | 1 |
| 136 | 2.51-26.7 | 1 |
| 137 | 2.7826 | 1 |
| 138 | 2.8390 | 1 |
| 139 | 2.9255 | 1 |
| 140 | 20.6ml/min/1.73m | 1 |
| 141 | 20/63 | 10 |
| 142 | 2004-11 | 1 |
| 143 | 2007-06/2008 | 1 |
| 144 | 20g/l | 4 |
| 145 | 210ma | 2 |
| 146 | 214° | 1 |
| 147 | 218.33 | 1 |
| 148 | 218.3ucarr | 1 |
| 149 | 22.9kj/m | 1 |
| 150 | 22.9°c | 1 |
| 151 | 22:00-07:00 | 3 |
| 152 | 22˚c | 1 |
| 153 | 23,147.3 | 1 |
| 154 | 23.9+/-9 | 1 |
| 155 | 233+/-156 | 1 |
| 156 | 23d | 2 |
| 157 | 24,885 | 1 |
| 158 | 2465.97 | 1 |
| 159 | 246k | 1 |
| 160 | 24min | 1 |
| 161 | 25-67°c | 1 |
| 162 | 25.3+/-2.5 | 1 |
| 163 | 26,168 | 1 |
| 164 | 26.1±1.7 | 1 |
| 165 | 264.16 | 1 |
| 166 | 269/440 | 1 |
| 167 | 27.2-66 | 1 |
| 168 | 273.17 | 1 |
| 169 | 2758+/-197 | 1 |
| 170 | 28,881 | 1 |
| 171 | 2th | 2 |
| 172 | 2θ | 2 |
| 173 | 3'-c-methyladenosine | 1 |
| 174 | 3+/5 | 1 |
| 175 | 3,4-diaryl-2,5-dihydrothiophenes | 2 |
| 176 | 3,6,9 | 1 |
| 177 | 3-benzoylpyridazines | 1 |
| 178 | 3-bromo-n- | 1 |
| 179 | 3-bromoquinolin-2 | 1 |
| 180 | 3-c-methyl-d-allose | 1 |
| 181 | 3-dimension-al | 1 |
| 182 | 3-mercaptohexanol | 1 |
| 183 | 3-methylpiperidine | 1 |
| 184 | 3-o-methylated- | 1 |
| 185 | 3-t. | 3 |
| 186 | 3-wp/fac | 1 |
| 187 | 3.0-t. | 1 |
| 188 | 3.3714 | 1 |
| 189 | 30,60,120 | 1 |
| 190 | 30.1-35.5°c | 1 |
| 191 | 300-700°c | 2 |
| 192 | 300mmhg | 1 |
| 193 | 300mpa | 1 |
| 194 | 31,000/mm | 1 |
| 195 | 31-102 | 1 |
| 196 | 31.25μg/ml | 1 |
| 197 | 31.2°c | 2 |
| 198 | 324/339 | 1 |
| 199 | 32pg/ml | 1 |
| 200 | 35.3°c | 2 |
| 201 | 35.6°c | 1 |
| 202 | 350mg/dl | 1 |
| 203 | 355.56 | 1 |
| 204 | 36.0-89.4 | 1 |
| 205 | 36/30°c | 1 |
| 206 | 368.24 | 2 |
| 207 | 37.0/100 | 1 |
| 208 | 385±28 | 1 |
| 209 | 390000 | 1 |
| 210 | 393/519 | 1 |
| 211 | 398/656 | 1 |
| 212 | 3´-azido-3´-deoxythymidine | 1 |
| 213 | 4,8,12,16,26 | 1 |
| 214 | 4-amino-6-methyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5 | 1 |
| 215 | 4-bromo-2-methoxyphenol | 1 |
| 216 | 4-hydroperoxy-2-nonenal | 1 |
| 217 | 4-methoxyaniline | 1 |
| 218 | 4-methylbenzaldehyde | 1 |
| 219 | 4.3×10 | 1 |
| 220 | 40-60°c | 1 |
| 221 | 43.5°c | 1 |
| 222 | 43.7±13.2iu/g | 1 |
| 223 | 45°-60° | 1 |
| 224 | 46-1,662 | 1 |
| 225 | 46.0°c | 3 |
| 226 | 46±3 | 1 |
| 227 | 48+/-4 | 1 |
| 228 | 490/603 | 1 |
| 229 | 4f5/2 | 2 |
| 230 | 4·04-2·88 | 1 |
| 231 | 5,806 | 1 |
| 232 | 5-acetyl-4-hydroxy-2h-1,3-thiazine-2,6 | 1 |
| 233 | 5-ethynylthiophene-2-sulfonamide | 1 |
| 234 | 5.2+/-3.8 | 1 |
| 235 | 5.29±2.3 | 1 |
| 236 | 5.8+/-0.049 | 1 |
| 237 | 50-60-70-80 | 1 |
| 238 | 500ng/ml | 3 |
| 239 | 50ºc | 3 |
| 240 | 51.1/10 | 1 |
| 241 | 525°c | 1 |
| 242 | 53.5microm/l | 1 |
| 243 | 544.06 | 1 |
| 244 | 58/81 | 1 |
| 245 | 5:4:13 | 1 |
| 246 | 5metg | 2 |
| 247 | 5p15.2pter | 1 |
| 248 | 5q35.3 | 2 |
| 249 | 6,12,18,24 | 1 |
| 250 | 6,249 | 1 |
| 251 | 6,600/mm | 1 |
| 252 | 6-acetyl-1,3,7-trimethyllumazine | 1 |
| 253 | 6-deoxy-d-glucal | 1 |
| 254 | 6-phenyl-4- | 2 |
| 255 | 6-trifluoromethylpyridine-2 | 1 |
| 256 | 6.3kj/m | 1 |
| 257 | 6.7+/-0.83 | 1 |
| 258 | 681studies | 1 |
| 259 | 690nm | 1 |
| 260 | 699.3 | 1 |
| 261 | 6p21.1 | 3 |
| 262 | 6th-graders | 1 |
| 263 | 7,476 | 1 |
| 264 | 7-38°c | 1 |
| 265 | 7-hydroxy-4-methylcoumarin | 1 |
| 266 | 7.1×10 | 1 |
| 267 | 7.3/10 | 3 |
| 268 | 7.87±8.14 | 1 |
| 269 | 700k | 1 |
| 270 | 700ºc | 1 |
| 271 | 72.0+/-11.4 | 1 |
| 272 | 730nm | 1 |
| 273 | 7567 | 1 |
| 274 | 798+/-13 | 1 |
| 275 | 7mpa | 1 |
| 276 | 8,275 | 1 |
| 277 | 8.00am | 1 |
| 278 | 8.2911 | 1 |
| 279 | 8.2±1.7j/m | 1 |
| 280 | 8.2±3.0 | 1 |
| 281 | 8.4557 | 1 |
| 282 | 8.62±9.85 | 1 |
| 283 | 80/min | 4 |
| 284 | 801.8 | 1 |
| 285 | 8013€ | 1 |
| 286 | 81.8±25.2 | 1 |
| 287 | 813±62 | 1 |
| 288 | 82-587 | 1 |
| 289 | 883.4 | 1 |
| 290 | 8pter | 1 |
| 291 | 9.0±20.8 | 1 |
| 292 | 9.3-63 | 1 |
| 293 | 9.3pg/ml | 1 |
| 294 | 90.42 | 1 |
| 295 | 98-110 | 1 |
| 296 | 996·7 | 1 |
| 297 | 9:00am | 2 |
| 298 | 9:4:7:6 | 1 |
| 299 | 9°c | 4 |
| 300 | 9α-hy-droxy-parthenolide | 3 |
| 301 | a752 | 1 |
| 302 | aaipharma | 1 |
| 303 | aatsr | 3 |
| 304 | abiotrophia | 1 |
| 305 | acandí | 1 |
| 306 | aceptable | 1 |
| 307 | acetoacetanilide | 1 |
| 308 | acm/c1-e* | 2 |
| 309 | acm/c3-aj | 1 |
| 310 | actn3-knockout | 1 |
| 311 | adcmedian | 4 |
| 312 | adherence/competence | 2 |
| 313 | advanced-age | 1 |
| 314 | advancent | 1 |
| 315 | ag525 | 1 |
| 316 | agarose-overlaid | 1 |
| 317 | agelanthus | 2 |
| 318 | ages‑induced | 1 |
| 319 | aidsinfo | 1 |
| 320 | alpha3beta3gamma2 | 1 |
| 321 | amia | 1 |
| 322 | androst-4-en-3,17-dione | 1 |
| 323 | another-and | 1 |
| 324 | antiinitiation | 1 |
| 325 | aquidauana | 1 |
| 326 | arbatax | 1 |
| 327 | arg45 | 1 |
| 328 | argonne | 2 |
| 329 | arm-level | 5 |
| 330 | arterio-to-mixed-venous | 1 |
| 331 | arylsulfonamides | 1 |
| 332 | asn27 | 1 |
| 333 | assessment-to-assessment | 2 |
| 334 | assobiomedica | 1 |
| 335 | atmospheric/soil | 1 |
| 336 | auschwitz | 2 |
| 337 | autoanti-di | 1 |
| 338 | baicheng | 1 |
| 339 | bar/restaurant | 8 |
| 340 | barasat | 3 |
| 341 | base-line | 71 |
| 342 | baseleine | 1 |
| 343 | baseline | 73,263 |
| 344 | baseline,1 | 1 |
| 345 | baseline-overload | 1 |
| 346 | baseline-posttreatment | 1 |
| 347 | baseline-to-post | 2 |
| 348 | baseline.due | 1 |
| 349 | baseline/follow-up | 3 |
| 350 | baseline/randomization | 1 |
| 351 | baseline=8.9 | 1 |
| 352 | basline | 2 |
| 353 | batna | 1 |
| 354 | beijng | 1 |
| 355 | bhagirathi | 1 |
| 356 | bhcel5b | 2 |
| 357 | bird-head | 1 |
| 358 | bis-methylene | 1 |
| 359 | bl-d7 | 1 |
| 360 | blank- | 1 |
| 361 | blue/green | 2 |
| 362 | boc-tyr-pro-oh | 1 |
| 363 | bolu | 1 |
| 364 | borreria | 2 |
| 365 | bothvb1 | 1 |
| 366 | bott | 1 |
| 367 | breast/ovarian- | 1 |
| 368 | bucally | 2 |
| 369 | bush-doctors | 1 |
| 370 | c25 | 1 |
| 371 | c38 | 1 |
| 372 | c4c5 | 1 |
| 373 | c57bl/6-tg | 1 |
| 374 | c6/7 | 2 |
| 375 | c646 | 1 |
| 376 | c6c7 | 1 |
| 377 | ca-fa | 2 |
| 378 | campanian-maastrichtian | 1 |
| 379 | caprines | 1 |
| 380 | carboxyhaemoglobinaemia | 1 |
| 381 | cardio2000 | 1 |
| 382 | case-database | 1 |
| 383 | cause- | 1 |
| 384 | cbma | 1 |
| 385 | cellminer | 5 |
| 386 | cetingrad | 1 |
| 387 | chama | 2 |
| 388 | chares | 3 |
| 389 | check-lists | 2 |
| 390 | chendring | 1 |
| 391 | chinnallapuram | 1 |
| 392 | chloromethylmethoxypsoralen | 1 |
| 393 | choma | 1 |
| 394 | chondroitin-4-sulfate | 1 |
| 395 | chuk1 | 1 |
| 396 | clc-3-/- | 1 |
| 397 | clofibrinic | 1 |
| 398 | close-to-optimal | 1 |
| 399 | cobolt-60 | 1 |
| 400 | codont | 1 |
| 401 | colposcopic/bioptic | 1 |
| 402 | cona-activated | 1 |
| 403 | conciliation | 1 |
| 404 | cord-csf | 2 |
| 405 | core-foods | 1 |
| 406 | cox5-6 | 1 |
| 407 | coxalgia | 1 |
| 408 | cpap10 | 1 |
| 409 | cran | 1 |
| 410 | cross-purposes | 1 |
| 411 | cueva | 1 |
| 412 | cuso4•5h2o | 1 |
| 413 | cv23 | 1 |
| 414 | cycle-3 | 2 |
| 415 | c₄₀₋₆₄ | 1 |
| 416 | d.e.s.i.r. | 1 |
| 417 | d01 | 1 |
| 418 | d13 | 5 |
| 419 | database-deposited | 1 |
| 420 | day-2 | 18 |
| 421 | daybreak | 1 |
| 422 | dbgap | 1 |
| 423 | deoxyuridylate | 1 |
| 424 | dermatophagoidesfarina | 2 |
| 425 | diagnosis-injection | 1 |
| 426 | dimethyphtalate | 1 |
| 427 | discharge-bun | 1 |
| 428 | doctors/hospitals | 1 |
| 429 | doddaballapur | 1 |
| 430 | dose-linearity | 2 |
| 431 | dry-off | 19 |
| 432 | dry/nonproductive | 1 |
| 433 | drying-off | 7 |
| 434 | duhok | 1 |
| 435 | dunavant | 1 |
| 436 | dyspnoes | 1 |
| 437 | e11.5-12.5 | 1 |
| 438 | e11.5-15.5 | 1 |
| 439 | e9.5-12.5 | 1 |
| 440 | echo-pressure | 1 |
| 441 | echo-tracked | 1 |
| 442 | egfr-treated | 1 |
| 443 | ego-resiliency | 3 |
| 444 | el-aghwar | 2 |
| 445 | eml2 | 1 |
| 446 | end-expiration | 15 |
| 447 | end-of-core | 1 |
| 448 | end-of-diastole | 1 |
| 449 | endocrinometabolic | 1 |
| 450 | epikur | 1 |
| 451 | errant | 4 |
| 452 | eses-treatment | 1 |
| 453 | eucosterol | 1 |
| 454 | euro226.57 | 1 |
| 455 | f127/hpmc | 1 |
| 456 | ferrell | 1 |
| 457 | ferrous/ferric- | 1 |
| 458 | fish-miso | 1 |
| 459 | foreplay | 2 |
| 460 | freelist | 4 |
| 461 | freetest.me | 1 |
| 462 | fty720-treated | 1 |
| 463 | fundhacre | 1 |
| 464 | g1-g5 | 1 |
| 465 | g3b | 1 |
| 466 | gainp | 1 |
| 467 | galia | 2 |
| 468 | gaoliang | 1 |
| 469 | germline-enriched | 1 |
| 470 | gln16 | 1 |
| 471 | gongzhuling | 1 |
| 472 | grimmen | 1 |
| 473 | gynecologists/urogynecologists | 1 |
| 474 | gynecomastias | 1 |
| 475 | görlitz | 1 |
| 476 | gαs | 3 |
| 477 | half-scan | 2 |
| 478 | hansatech | 1 |
| 479 | haughty | 1 |
| 480 | hemimorphite | 1 |
| 481 | hexa-ni | 1 |
| 482 | hexian | 1 |
| 483 | hfc-245fa | 1 |
| 484 | hif-inhibitors | 1 |
| 485 | high-enough | 1 |
| 486 | high-temperatures | 4 |
| 487 | higher-titer | 1 |
| 488 | hiv-acquisition | 1 |
| 489 | holo-protein | 1 |
| 490 | hospital-ward | 1 |
| 491 | hospital.5 | 1 |
| 492 | hospital/regional | 1 |
| 493 | hospitalizedpatients | 1 |
| 494 | hrp/rhr | 2 |
| 495 | ht09 | 5 |
| 496 | huntsville | 2 |
| 497 | hyptonia | 1 |
| 498 | igane | 1 |
| 499 | il-27r | 1 |
| 500 | in-stent-restenosis | 1 |
| 501 | inkosi | 3 |
| 502 | inositol-p-ceramide | 1 |
| 503 | intergeneric | 1 |
| 504 | intra-f | 1 |
| 505 | intraoperation | 14 |
| 506 | ipl/tssc3/bwr1c | 1 |
| 507 | ir-exposed | 1 |
| 508 | isla | 1 |
| 509 | isoosmolality | 1 |
| 510 | italian- | 1 |
| 511 | jangseong | 1 |
| 512 | jeotgal | 1 |
| 513 | jiaxing | 1 |
| 514 | jim | 3 |
| 515 | jungfraujoch | 4 |
| 516 | k-puszta | 1 |
| 517 | kasr | 6 |
| 518 | kir3 | 2 |
| 519 | kloppe | 1 |
| 520 | kmgf3 | 1 |
| 521 | kwok | 1 |
| 522 | l3-s1 | 1 |
| 523 | l52 | 5 |
| 524 | lankaran | 1 |
| 525 | lappro | 1 |
| 526 | lc-ωpbe | 1 |
| 527 | ldl-precursors | 1 |
| 528 | left-censored | 1 |
| 529 | leucoplakia | 3 |
| 530 | li2c2o5 | 1 |
| 531 | live-online | 1 |
| 532 | lmax | 30 |
| 533 | log-normality | 1 |
| 534 | louata | 1 |
| 535 | low/highly-perturbed | 1 |
| 536 | luzon | 3 |
| 537 | lvov | 1 |
| 538 | m-pst | 4 |
| 539 | mainling | 1 |
| 540 | malay-balay | 1 |
| 541 | maljen | 1 |
| 542 | mcpa | 1 |
| 543 | me2culi⋅lisph | 1 |
| 544 | meat- | 1 |
| 545 | medawachchiya | 2 |
| 546 | mendota | 1 |
| 547 | merck-medco | 1 |
| 548 | mesolithic | 1 |
| 549 | metformin/sulfonylureas | 1 |
| 550 | methimazole- | 1 |
| 551 | methoxy-poly | 1 |
| 552 | metzner | 1 |
| 553 | mex-5/6 | 1 |
| 554 | micro-ulcers | 1 |
| 555 | mid-calf | 5 |
| 556 | mid-duodenum | 1 |
| 557 | mid-tens | 1 |
| 558 | midpregnancy | 29 |
| 559 | midtraining | 9 |
| 560 | midtreatment | 26 |
| 561 | mithocondria | 1 |
| 562 | mixed-occupied | 1 |
| 563 | mn3sn | 1 |
| 564 | mock- | 1 |
| 565 | moct1/2 | 1 |
| 566 | moet- | 1 |
| 567 | mogadishu | 1 |
| 568 | mongu | 1 |
| 569 | mononitrotetrakis | 1 |
| 570 | moravek | 1 |
| 571 | motuo | 1 |
| 572 | mp2/aug-cc-pvdz | 1 |
| 573 | ms4a4e | 2 |
| 574 | msh4 | 1 |
| 575 | mutated-type | 1 |
| 576 | n-alkyl- | 1 |
| 577 | n-bn | 1 |
| 578 | naprp | 1 |
| 579 | narezushi | 1 |
| 580 | nawarangapur | 1 |
| 581 | nct01008033 | 1 |
| 582 | ndirande | 1 |
| 583 | near-conscious | 2 |
| 584 | nicotine/cotinine/3-oh-cot | 1 |
| 585 | nigerien | 1 |
| 586 | ninhydrine | 1 |
| 587 | non-achd | 1 |
| 588 | non-mtrps | 1 |
| 589 | nonhealers | 1 |
| 590 | nontransamidated | 1 |
| 591 | normoleptinemic | 1 |
| 592 | north-america | 3 |
| 593 | nuts-1 | 1 |
| 594 | nyanga | 1 |
| 595 | nyingchi | 1 |
| 596 | o-alkynyl-n | 1 |
| 597 | o-vinylbenzaldehyde | 1 |
| 598 | okpanku | 1 |
| 599 | oncoantigens | 1 |
| 600 | over-regulation | 1 |
| 601 | over-stress | 1 |
| 602 | ozonytronx | 1 |
| 603 | p-nitrotoluene | 1 |
| 604 | p1024 | 3 |
| 605 | p550 | 1 |
| 606 | p73-deficient | 1 |
| 607 | palencia | 1 |
| 608 | palref | 3 |
| 609 | paraphenylenediamine | 2 |
| 610 | pardis | 1 |
| 611 | parthenin | 1 |
| 612 | participants.weight-for-age | 1 |
| 613 | pbd4 | 1 |
| 614 | peracarida | 1 |
| 615 | peridiverticulitis | 1 |
| 616 | ph.d.p. | 1 |
| 617 | ph=6 | 1 |
| 618 | phanerobranchia | 1 |
| 619 | photocopiers | 2 |
| 620 | ph≥7 | 1 |
| 621 | picrasma | 2 |
| 622 | pikas | 1 |
| 623 | pinane- | 1 |
| 624 | pn21 | 1 |
| 625 | population-recruited | 1 |
| 626 | post-first-injection | 1 |
| 627 | post-immediately | 1 |
| 628 | post-trascriptional | 1 |
| 629 | postprotocol | 4 |
| 630 | postrest | 4 |
| 631 | pound4,261 | 1 |
| 632 | power-from-within | 1 |
| 633 | pre-apprentices | 1 |
| 634 | pre-bi | 3 |
| 635 | pre-blooming | 1 |
| 636 | pre-bpv | 1 |
| 637 | pre-clamp | 5 |
| 638 | pre-delirium | 2 |
| 639 | pre-immigration | 1 |
| 640 | pre-infusion | 13 |
| 641 | pre-ingestion | 9 |
| 642 | pre-intervention | 334 |
| 643 | pre-lbnp | 5 |
| 644 | pre-occlusion | 4 |
| 645 | pre-pace | 1 |
| 646 | pre-pbmv | 2 |
| 647 | pre-ptca | 4 |
| 648 | pre-qin | 2 |
| 649 | pre-rehabilitative | 3 |
| 650 | pre-sbt | 3 |
| 651 | pre-to-posttreatment | 1 |
| 652 | pre-transition | 5 |
| 653 | pre-work | 3 |
| 654 | preassessment | 13 |
| 655 | preinfection | 8 |
| 656 | preingestion | 8 |
| 657 | prenitroglycerin | 2 |
| 658 | prenosological | 1 |
| 659 | preoperation | 24 |
| 660 | preoxygenator | 1 |
| 661 | preproenkephalin | 1 |
| 662 | preruminants | 1 |
| 663 | presitting | 2 |
| 664 | pressure-volume-temperature | 1 |
| 665 | prestretching | 5 |
| 666 | pretraining | 90 |
| 667 | pretreatmer | 1 |
| 668 | prewash | 4 |
| 669 | privately- | 1 |
| 670 | pro-tk-subtilisin | 1 |
| 671 | providers/clinics | 1 |
| 672 | pseudokeratosis | 1 |
| 673 | p≤0·025 | 1 |
| 674 | q312 | 1 |
| 675 | queenscliff | 1 |
| 676 | r-30 | 1 |
| 677 | radio-meter | 1 |
| 678 | radon-222 | 1 |
| 679 | regional/tertiary | 1 |
| 680 | regshospitalet | 1 |
| 681 | remitted-recurrent | 1 |
| 682 | rerevascularization | 1 |
| 683 | rest/cough | 1 |
| 684 | rest/lvef | 1 |
| 685 | rest/postprandial/during | 1 |
| 686 | rhic | 1 |
| 687 | riks-stroke | 1 |
| 688 | rpe13 | 5 |
| 689 | rs12130333 | 3 |
| 690 | rs1685354 | 1 |
| 691 | s2481 | 1 |
| 692 | s83i | 2 |
| 693 | sagae-shi | 1 |
| 694 | sbm-bound | 1 |
| 695 | scadding | 1 |
| 696 | scbr | 5 |
| 697 | self-preoccupation | 1 |
| 698 | ser-367 | 2 |
| 699 | ser-54 | 1 |
| 700 | ser-587 | 1 |
| 701 | ser33/37 | 2 |
| 702 | ser385 | 1 |
| 703 | ser635 | 1 |
| 704 | ser69 | 2 |
| 705 | serine473 | 1 |
| 706 | serologist | 1 |
| 707 | service-entry | 1 |
| 708 | sesuvium | 1 |
| 709 | sf36-fd | 1 |
| 710 | shillong | 1 |
| 711 | short-gap | 1 |
| 712 | sinaloa | 5 |
| 713 | sinikithemba | 2 |
| 714 | sleep/attention | 1 |
| 715 | small-arteries | 1 |
| 716 | small-trials | 1 |
| 717 | sogn | 1 |
| 718 | sopungsunkiwon | 1 |
| 719 | speech-act | 1 |
| 720 | st18 | 1 |
| 721 | state-to-state | 1 |
| 722 | stimulator- | 1 |
| 723 | subbloom | 1 |
| 724 | subpasteurization | 1 |
| 725 | suihua | 1 |
| 726 | swespine | 1 |
| 727 | symptoms/events | 1 |
| 728 | t11-12 | 1 |
| 729 | t12/l1 | 1 |
| 730 | t5-t8 | 2 |
| 731 | t5· | 1 |
| 732 | t6h | 2 |
| 733 | t=20 | 1 |
| 734 | terena | 1 |
| 735 | tetrapak | 1 |
| 736 | tex4 | 2 |
| 737 | th4-th5 | 1 |
| 738 | the-medical | 1 |
| 739 | thermo-sensitisation | 2 |
| 740 | thermonuetral | 1 |
| 741 | thielaviopsis | 2 |
| 742 | thr-696 | 1 |
| 743 | three-randomized | 1 |
| 744 | threonine-181 | 1 |
| 745 | tippb | 8 |
| 746 | tms- | 1 |
| 747 | tmz/rt | 1 |
| 748 | topographic- | 1 |
| 749 | torremolinos | 1 |
| 750 | tpf-ccrt | 2 |
| 751 | trackvis | 1 |
| 752 | trans-2-aroyl-3-aryl-cyclopropane-1,1-dicarboxylates | 1 |
| 753 | trans-gauche | 1 |
| 754 | tributed | 1 |
| 755 | trimpark | 1 |
| 756 | trinitrophenylated | 2 |
| 757 | trisaturated | 1 |
| 758 | trnaglu-trnaphe | 1 |
| 759 | trois-rivières | 1 |
| 760 | trøndelag | 1 |
| 761 | tuesday | 7 |
| 762 | turn-out | 1 |
| 763 | u121 | 1 |
| 764 | ufr-mdm | 2 |
| 765 | ulcer/erosion | 1 |
| 766 | unclear/high | 3 |
| 767 | unpopularity | 1 |
| 768 | usd791 | 1 |
| 769 | uti-infants | 1 |
| 770 | varibench | 1 |
| 771 | vero- | 1 |
| 772 | vince | 1 |
| 773 | viups | 1 |
| 774 | vo2net | 1 |
| 775 | w16 | 7 |
| 776 | walk-around | 1 |
| 777 | warfarin-elevated | 1 |
| 778 | webthal® | 1 |
| 779 | weeks-4 | 1 |
| 780 | weifang | 2 |
| 781 | whangapoua | 1 |
| 782 | whccs | 1 |
| 783 | wk-01 | 4 |
| 784 | workshop-floors | 1 |
| 785 | wuzhou | 1 |
| 786 | www.cri-net.com | 1 |
| 787 | x=0.3 | 1 |
| 788 | xianyang | 1 |
| 789 | xionghuang | 1 |
| 790 | xocotitla | 1 |
| 791 | xq21.3 | 4 |
| 792 | yang-meridian | 1 |
| 793 | years-5 | 1 |
| 794 | yongding | 1 |
| 795 | youtube.com | 1 |
| 796 | yuanlijian | 1 |
| 797 | £13,290 | 1 |
| 798 | £3002/patient | 1 |
| 799 | £3855/qaly | 1 |
| 800 | α-napthylamine | 1 |
| 801 | α-silyl- | 1 |
| 802 | α-trifluoromethyl-α | 1 |
| 803 | α4β2- | 3 |
| 804 | α4β4- | 1 |
| 805 | αs- | 1 |
| 806 | δes | 6 |
| 807 | δmg/cm2/min/°c | 1 |
| 808 | δmyoglobin | 1 |
| 809 | €2430 | 1 |
| 810 | €3011/qaly | 1 |
| 811 | €33,500 | 1 |
| 812 | €6520 | 1 |
| 813 | €788 | 1 |
| 814 | €8000/qaly | 1 |
| 815 | ∼240 | 1 |
| 816 | ∼404 | 1 |
| 817 | ∼688 | 1 |
| 1 | acm/c1-e* | 2 |
| 2 | 2-oxo-n'- | 1 |
| 3 | clc-3-/- | 1 |
| 4 | α4β2- | 3 |
| 5 | 6-phenyl-4- | 2 |
| 6 | α4β4- | 1 |
| 7 | topographic- | 1 |
| 8 | ferrous/ferric- | 1 |
| 9 | 3-o-methylated- | 1 |
| 10 | methimazole- | 1 |
| 11 | pinane- | 1 |
| 12 | cause- | 1 |
| 13 | mock- | 1 |
| 14 | blank- | 1 |
| 15 | n-alkyl- | 1 |
| 16 | α-silyl- | 1 |
| 17 | 3-bromo-n- | 1 |
| 18 | italian- | 1 |
| 19 | breast/ovarian- | 1 |
| 20 | vero- | 1 |
| 21 | stimulator- | 1 |
| 22 | tms- | 1 |
| 23 | αs- | 1 |
| 24 | meat- | 1 |
| 25 | moet- | 1 |
| 26 | privately- | 1 |
| 27 | ph.d.p. | 1 |
| 28 | d.e.s.i.r. | 1 |
| 29 | 3.0-t. | 1 |
| 30 | 3-t. | 3 |
| 31 | 11+0 | 10 |
| 32 | 8.2±3.0 | 1 |
| 33 | 1/1/99-12/31/00 | 1 |
| 34 | 390000 | 1 |
| 35 | 0.58/1000 | 1 |
| 36 | cardio2000 | 1 |
| 37 | 37.0/100 | 1 |
| 38 | €33,500 | 1 |
| 39 | 22:00-07:00 | 3 |
| 40 | 51.1/10 | 1 |
| 41 | 7.3/10 | 3 |
| 42 | 98-110 | 1 |
| 43 | cpap10 | 1 |
| 44 | 0.6x10 | 1 |
| 45 | 7.1×10 | 1 |
| 46 | 0.61×10 | 1 |
| 47 | 4.3×10 | 1 |
| 48 | 2.13×10 | 1 |
| 49 | 30,60,120 | 1 |
| 50 | 191/220 | 1 |
| 51 | €6520 | 1 |
| 52 | t=20 | 1 |
| 53 | 1∶20 | 3 |
| 54 | r-30 | 1 |
| 55 | €2430 | 1 |
| 56 | 05:30 | 3 |
| 57 | 118/240 | 1 |
| 58 | ∼240 | 1 |
| 59 | 269/440 | 1 |
| 60 | p550 | 1 |
| 61 | cobolt-60 | 1 |
| 62 | 50-60-70-80 | 1 |
| 63 | 1974-90 | 1 |
| 64 | £13,290 | 1 |
| 65 | 2.8390 | 1 |
| 66 | 1.7690 | 1 |
| 67 | baseline,1 | 1 |
| 68 | nuts-1 | 1 |
| 69 | 145.4/80.1 | 1 |
| 70 | 6p21.1 | 3 |
| 71 | 128.4±22.1 | 1 |
| 72 | 164.1±33.1 | 1 |
| 73 | wk-01 | 4 |
| 74 | d01 | 1 |
| 75 | 2004-11 | 1 |
| 76 | 0.71±0.11 | 1 |
| 77 | 101/111 | 1 |
| 78 | 8.2911 | 1 |
| 79 | u121 | 1 |
| 80 | pn21 | 1 |
| 81 | pound4,261 | 1 |
| 82 | 58/81 | 1 |
| 83 | threonine-181 | 1 |
| 84 | s2481 | 1 |
| 85 | 28,881 | 1 |
| 86 | usd791 | 1 |
| 87 | 1956-1991 | 1 |
| 88 | bothvb1 | 1 |
| 89 | chuk1 | 1 |
| 90 | t12/l1 | 1 |
| 91 | l3-s1 | 1 |
| 92 | 6-trifluoromethylpyridine-2 | 1 |
| 93 | 3-bromoquinolin-2 | 1 |
| 94 | day-2 | 18 |
| 95 | 0.8:0.2 | 1 |
| 96 | 81.8±25.2 | 1 |
| 97 | moct1/2 | 1 |
| 98 | 4f5/2 | 2 |
| 99 | 31-102 | 1 |
| 100 | t11-12 | 1 |
| 101 | 05.03.2012 | 1 |
| 102 | q312 | 1 |
| 103 | radon-222 | 1 |
| 104 | 90.42 | 1 |
| 105 | a752 | 1 |
| 106 | l52 | 5 |
| 107 | 46-1,662 | 1 |
| 108 | 813±62 | 1 |
| 109 | 1146±182 | 1 |
| 110 | alpha3beta3gamma2 | 1 |
| 111 | eml2 | 1 |
| 112 | 0,2,3 | 1 |
| 113 | cycle-3 | 2 |
| 114 | x=0.3 | 1 |
| 115 | 15.2±0.3 | 1 |
| 116 | xq21.3 | 4 |
| 117 | 5.29±2.3 | 1 |
| 118 | 5q35.3 | 2 |
| 119 | 23,147.3 | 1 |
| 120 | 699.3 | 1 |
| 121 | 0.89±1.03 | 1 |
| 122 | 490/603 | 1 |
| 123 | 798+/-13 | 1 |
| 124 | 1995-2013 | 1 |
| 125 | 19,613 | 1 |
| 126 | 5:4:13 | 1 |
| 127 | d13 | 5 |
| 128 | rpe13 | 5 |
| 129 | cv23 | 1 |
| 130 | 218.33 | 1 |
| 131 | nct01008033 | 1 |
| 132 | rs12130333 | 3 |
| 133 | 9.3-63 | 1 |
| 134 | 20/63 | 10 |
| 135 | serine473 | 1 |
| 136 | 6.7+/-0.83 | 1 |
| 137 | 1969-1983 | 1 |
| 138 | 157/93 | 1 |
| 139 | 0-1793 | 1 |
| 140 | kmgf3 | 1 |
| 141 | kir3 | 2 |
| 142 | 46±3 | 1 |
| 143 | 48+/-4 | 1 |
| 144 | weeks-4 | 1 |
| 145 | 72.0+/-11.4 | 1 |
| 146 | 883.4 | 1 |
| 147 | 36.0-89.4 | 1 |
| 148 | 1985-2004 | 5 |
| 149 | ∼404 | 1 |
| 150 | 7.87±8.14 | 1 |
| 151 | 3.3714 | 1 |
| 152 | 6,12,18,24 | 1 |
| 153 | 0.8-24 | 1 |
| 154 | 368.24 | 2 |
| 155 | p1024 | 3 |
| 156 | 142.34 | 1 |
| 157 | 183±44 | 1 |
| 158 | 1947-54 | 1 |
| 159 | ser-54 | 1 |
| 160 | 1250-1254 | 1 |
| 161 | rs1685354 | 1 |
| 162 | 1.19-2.64 | 1 |
| 163 | 17.93±1.84 | 1 |
| 164 | 149/94 | 2 |
| 165 | pbd4 | 1 |
| 166 | msh4 | 1 |
| 167 | tex4 | 2 |
| 168 | 4-amino-6-methyl-3-thioxo-3,4-dihydro-1,2,4-triazin-5 | 1 |
| 169 | years-5 | 1 |
| 170 | 1.6-10.5 | 1 |
| 171 | 25.3+/-2.5 | 1 |
| 172 | e11.5-12.5 | 1 |
| 173 | e9.5-12.5 | 1 |
| 174 | e11.5-15.5 | 1 |
| 175 | 18.8-24.1/11.7-15.5 | 1 |
| 176 | hospital.5 | 1 |
| 177 | 3+/5 | 1 |
| 178 | 1.04-1.05 | 1 |
| 179 | p≤0·025 | 1 |
| 180 | 101.325 | 1 |
| 181 | ag525 | 1 |
| 182 | c25 | 1 |
| 183 | 12.32+/-4.35 | 1 |
| 184 | 189.35 | 1 |
| 185 | ser635 | 1 |
| 186 | 11:45 | 4 |
| 187 | arg45 | 1 |
| 188 | 2.09±0.55 | 1 |
| 189 | 2.9255 | 1 |
| 190 | 1·075 | 1 |
| 191 | 8,275 | 1 |
| 192 | 1971-1975 | 2 |
| 193 | 8.62±9.85 | 1 |
| 194 | ser385 | 1 |
| 195 | 24,885 | 1 |
| 196 | 183.95 | 1 |
| 197 | c4c5 | 1 |
| 198 | g1-g5 | 1 |
| 199 | th4-th5 | 1 |
| 200 | li2c2o5 | 1 |
| 201 | 5-acetyl-4-hydroxy-2h-1,3-thiazine-2,6 | 1 |
| 202 | cox5-6 | 1 |
| 203 | 1.8+/-0.6 | 2 |
| 204 | 14.6+/-4.6 | 1 |
| 205 | mex-5/6 | 1 |
| 206 | 544.06 | 1 |
| 207 | 1978-2006 | 1 |
| 208 | 5,806 | 1 |
| 209 | 264.16 | 1 |
| 210 | gln16 | 1 |
| 211 | w16 | 7 |
| 212 | 4,8,12,16,26 | 1 |
| 213 | 2.7826 | 1 |
| 214 | 12,24,36 | 1 |
| 215 | 0.44±0.46 | 1 |
| 216 | c646 | 1 |
| 217 | 0.25±0.56 | 1 |
| 218 | 355.56 | 1 |
| 219 | 233+/-156 | 1 |
| 220 | 1-256 | 1 |
| 221 | 12.5-356 | 1 |
| 222 | 398/656 | 1 |
| 223 | 27.2-66 | 1 |
| 224 | 14,866 | 1 |
| 225 | 7,476 | 1 |
| 226 | thr-696 | 1 |
| 227 | 9:4:7:6 | 1 |
| 228 | ph=6 | 1 |
| 229 | 26.1±1.7 | 1 |
| 230 | 2.51-26.7 | 1 |
| 231 | 121/7 | 1 |
| 232 | c6/7 | 2 |
| 233 | 1952-2007 | 2 |
| 234 | 273.17 | 1 |
| 235 | asn27 | 1 |
| 236 | ser33/37 | 2 |
| 237 | euro226.57 | 1 |
| 238 | 8.4557 | 1 |
| 239 | 1959-67 | 1 |
| 240 | 0.2167 | 1 |
| 241 | ser-367 | 2 |
| 242 | 7567 | 1 |
| 243 | 2.3667 | 1 |
| 244 | 1958-1967 | 1 |
| 245 | 82-587 | 1 |
| 246 | ser-587 | 1 |
| 247 | 0.1687 | 1 |
| 248 | 2465.97 | 1 |
| 249 | 2758+/-197 | 1 |
| 250 | c6c7 | 1 |
| 251 | bl-d7 | 1 |
| 252 | ph≥7 | 1 |
| 253 | 996·7 | 1 |
| 254 | 1,2,4,8 | 1 |
| 255 | 0,2,4,6,8 | 1 |
| 256 | 9.0±20.8 | 1 |
| 257 | 801.8 | 1 |
| 258 | 5.2+/-3.8 | 1 |
| 259 | 166.4/85.8 | 1 |
| 260 | 2007-06/2008 | 1 |
| 261 | 108.108 | 1 |
| 262 | 193/218 | 1 |
| 263 | st18 | 1 |
| 264 | 385±28 | 1 |
| 265 | c38 | 1 |
| 266 | 26,168 | 1 |
| 267 | -178 | 7 |
| 268 | ∼688 | 1 |
| 269 | €788 | 1 |
| 270 | 4·04-2·88 | 1 |
| 271 | 143.98 | 1 |
| 272 | t5-t8 | 2 |
| 273 | 3,6,9 | 1 |
| 274 | 23.9+/-9 | 1 |
| 275 | 2,630.9 | 2 |
| 276 | baseline=8.9 | 1 |
| 277 | 0.53+/-0.09 | 1 |
| 278 | 1940-2009 | 1 |
| 279 | ht09 | 5 |
| 280 | 1-119 | 1 |
| 281 | 393/519 | 1 |
| 282 | -919 | 3 |
| 283 | 324/339 | 1 |
| 284 | 5.8+/-0.049 | 1 |
| 285 | 6,249 | 1 |
| 286 | ser69 | 2 |
| 287 | sinikithemba | 2 |
| 288 | assobiomedica | 1 |
| 289 | north-america | 3 |
| 290 | pre-ptca | 4 |
| 291 | peracarida | 1 |
| 292 | ca-fa | 2 |
| 293 | hfc-245fa | 1 |
| 294 | nyanga | 1 |
| 295 | palencia | 1 |
| 296 | coxalgia | 1 |
| 297 | phanerobranchia | 1 |
| 298 | abiotrophia | 1 |
| 299 | leucoplakia | 3 |
| 300 | galia | 2 |
| 301 | amia | 1 |
| 302 | carboxyhaemoglobinaemia | 1 |
| 303 | hyptonia | 1 |
| 304 | mithocondria | 1 |
| 305 | borreria | 2 |
| 306 | isla | 1 |
| 307 | xocotitla | 1 |
| 308 | 210ma | 2 |
| 309 | chama | 2 |
| 310 | cbma | 1 |
| 311 | choma | 1 |
| 312 | aaipharma | 1 |
| 313 | picrasma | 2 |
| 314 | aquidauana | 1 |
| 315 | terena | 1 |
| 316 | dermatophagoidesfarina | 2 |
| 317 | batna | 1 |
| 318 | sinaloa | 5 |
| 319 | mcpa | 1 |
| 320 | 300mpa | 1 |
| 321 | -48.3±1.5mpa | 1 |
| 322 | 7mpa | 1 |
| 323 | louata | 1 |
| 324 | mendota | 1 |
| 325 | k-puszta | 1 |
| 326 | suihua | 1 |
| 327 | whangapoua | 1 |
| 328 | cueva | 1 |
| 329 | medawachchiya | 2 |
| 330 | g3b | 1 |
| 331 | bhcel5b | 2 |
| 332 | tippb | 8 |
| 333 | ipl/tssc3/bwr1c | 1 |
| 334 | 3-wp/fac | 1 |
| 335 | 'episodic | 1 |
| 336 | rhic | 1 |
| 337 | mesolithic | 1 |
| 338 | endocrinometabolic | 1 |
| 339 | normoleptinemic | 1 |
| 340 | clofibrinic | 1 |
| 341 | intergeneric | 1 |
| 342 | colposcopic/bioptic | 1 |
| 343 | f127/hpmc | 1 |
| 344 | 22˚c | 1 |
| 345 | δmg/cm2/min/°c | 1 |
| 346 | 46.0°c | 3 |
| 347 | 300-700°c | 2 |
| 348 | 36/30°c | 1 |
| 349 | 40-60°c | 1 |
| 350 | +1.1°c | 2 |
| 351 | 31.2°c | 2 |
| 352 | 35.3°c | 2 |
| 353 | 43.5°c | 1 |
| 354 | 30.1-35.5°c | 1 |
| 355 | 525°c | 1 |
| 356 | 35.6°c | 1 |
| 357 | 15-37°c | 1 |
| 358 | 25-67°c | 1 |
| 359 | 7-38°c | 1 |
| 360 | 9°c | 4 |
| 361 | 22.9°c | 1 |
| 362 | 149°c | 2 |
| 363 | 700ºc | 1 |
| 364 | 50ºc | 3 |
| 365 | -2.44±1.00d | 1 |
| 366 | 23d | 2 |
| 367 | bird-head | 1 |
| 368 | baseline-overload | 1 |
| 369 | cetingrad | 1 |
| 370 | low/highly-perturbed | 1 |
| 371 | ages‑induced | 1 |
| 372 | germline-enriched | 1 |
| 373 | mixed-occupied | 1 |
| 374 | echo-tracked | 1 |
| 375 | left-censored | 1 |
| 376 | ir-exposed | 1 |
| 377 | nontransamidated | 1 |
| 378 | fty720-treated | 1 |
| 379 | egfr-treated | 1 |
| 380 | trinitrophenylated | 2 |
| 381 | trisaturated | 1 |
| 382 | warfarin-elevated | 1 |
| 383 | cona-activated | 1 |
| 384 | database-deposited | 1 |
| 385 | population-recruited | 1 |
| 386 | tributed | 1 |
| 387 | three-randomized | 1 |
| 388 | sf36-fd | 1 |
| 389 | non-achd | 1 |
| 390 | agarose-overlaid | 1 |
| 391 | another-and | 1 |
| 392 | sbm-bound | 1 |
| 393 | walk-around | 1 |
| 394 | hospital-ward | 1 |
| 395 | ms4a4e | 2 |
| 396 | lc-ωpbe | 1 |
| 397 | pre-pace | 1 |
| 398 | adherence/competence | 2 |
| 399 | vince | 1 |
| 400 | acetoacetanilide | 1 |
| 401 | 9α-hy-droxy-parthenolide | 3 |
| 402 | 5-ethynylthiophene-2-sulfonamide | 1 |
| 403 | inositol-p-ceramide | 1 |
| 404 | 2,3,5,4'-tetrahydroxystilbene-2-o-β-glucoside | 1 |
| 405 | ndirande | 1 |
| 406 | 2-oxo-quinoline-3-carbaldehyde | 1 |
| 407 | 4-methylbenzaldehyde | 1 |
| 408 | o-vinylbenzaldehyde | 1 |
| 409 | advanced-age | 1 |
| 410 | participants.weight-for-age | 1 |
| 411 | trans-gauche | 1 |
| 412 | trnaglu-trnaphe | 1 |
| 413 | riks-stroke | 1 |
| 414 | aceptable | 1 |
| 415 | 2-amino-nicotinonitrile | 1 |
| 416 | huntsville | 2 |
| 417 | end-of-diastole | 1 |
| 418 | freetest.me | 1 |
| 419 | igane | 1 |
| 420 | bis-methylene | 1 |
| 421 | 2-bromo-3,3,3-trifluoropropene | 2 |
| 422 | p-nitrotoluene | 1 |
| 423 | 2-chloro-1,3,5-trinitrobenzene | 1 |
| 424 | 3´-azido-3´-deoxythymidine | 1 |
| 425 | 2-cyanoguanidine | 1 |
| 426 | 3-methylpiperidine | 1 |
| 427 | 2'-azidouridine | 2 |
| 428 | baseleine | 1 |
| 429 | base-line | 71 |
| 430 | baseline | 73,263 |
| 431 | 4-methoxyaniline | 1 |
| 432 | live-online | 1 |
| 433 | basline | 2 |
| 434 | paraphenylenediamine | 2 |
| 435 | α-napthylamine | 1 |
| 436 | swespine | 1 |
| 437 | ninhydrine | 1 |
| 438 | 3'-c-methyladenosine | 1 |
| 439 | 6-acetyl-1,3,7-trimethyllumazine | 1 |
| 440 | argonne | 2 |
| 441 | androst-4-en-3,17-dione | 1 |
| 442 | kloppe | 1 |
| 443 | mutated-type | 1 |
| 444 | fundhacre | 1 |
| 445 | end-of-core | 1 |
| 446 | echo-pressure | 1 |
| 447 | pressure-volume-temperature | 1 |
| 448 | case-database | 1 |
| 449 | 2,3,4,6-tetrabenzylglucose | 1 |
| 450 | 3-c-methyl-d-allose | 1 |
| 451 | chondroitin-4-sulfate | 1 |
| 452 | dimethyphtalate | 1 |
| 453 | deoxyuridylate | 1 |
| 454 | 2-14c-acetate | 2 |
| 455 | state-to-state | 1 |
| 456 | hemimorphite | 1 |
| 457 | baseline.due | 1 |
| 458 | pre-rehabilitative | 3 |
| 459 | dry/nonproductive | 1 |
| 460 | intra-f | 1 |
| 461 | palref | 3 |
| 462 | rest/lvef | 1 |
| 463 | queenscliff | 1 |
| 464 | drying-off | 7 |
| 465 | dry-off | 19 |
| 466 | mid-calf | 5 |
| 467 | 0hpf | 1 |
| 468 | cord-csf | 2 |
| 469 | 1360±920iu/g | 1 |
| 470 | 43.7±13.2iu/g | 1 |
| 471 | trøndelag | 1 |
| 472 | 0.4ngg | 1 |
| 473 | 300mmhg | 1 |
| 474 | 0.10-mmol/kg | 2 |
| 475 | 2.50±0.33kg | 1 |
| 476 | weifang | 2 |
| 477 | gaoliang | 1 |
| 478 | xionghuang | 1 |
| 479 | xianyang | 1 |
| 480 | baicheng | 1 |
| 481 | scadding | 1 |
| 482 | yongding | 1 |
| 483 | prestretching | 5 |
| 484 | mainling | 1 |
| 485 | gongzhuling | 1 |
| 486 | pre-blooming | 1 |
| 487 | midtraining | 9 |
| 488 | pretraining | 90 |
| 489 | chendring | 1 |
| 490 | rest/postprandial/during | 1 |
| 491 | presitting | 2 |
| 492 | jiaxing | 1 |
| 493 | beijng | 1 |
| 494 | jangseong | 1 |
| 495 | shillong | 1 |
| 496 | c57bl/6-tg | 1 |
| 497 | 5metg | 2 |
| 498 | 10,000×g | 1 |
| 499 | 07:00-h | 1 |
| 500 | t6h | 2 |
| 501 | hansatech | 1 |
| 502 | varibench | 1 |
| 503 | jungfraujoch | 4 |
| 504 | unclear/high | 3 |
| 505 | rest/cough | 1 |
| 506 | high-enough | 1 |
| 507 | boc-tyr-pro-oh | 1 |
| 508 | me2culi⋅lisph | 1 |
| 509 | prewash | 4 |
| 510 | 2th | 2 |
| 511 | 2.5-month | 1 |
| 512 | s83i | 2 |
| 513 | pre-bi | 3 |
| 514 | autoanti-di | 1 |
| 515 | nyingchi | 1 |
| 516 | sagae-shi | 1 |
| 517 | narezushi | 1 |
| 518 | bhagirathi | 1 |
| 519 | hexa-ni | 1 |
| 520 | inkosi | 3 |
| 521 | acm/c3-aj | 1 |
| 522 | 700k | 1 |
| 523 | 1a-1k | 1 |
| 524 | 246k | 1 |
| 525 | daybreak | 1 |
| 526 | tetrapak | 1 |
| 527 | 0-week | 6 |
| 528 | moravek | 1 |
| 529 | duhok | 1 |
| 530 | kwok | 1 |
| 531 | trimpark | 1 |
| 532 | pre-work | 3 |
| 533 | 20g/l | 4 |
| 534 | 11μmol/l | 1 |
| 535 | 18.2μmol/l | 1 |
| 536 | 53.5microm/l | 1 |
| 537 | 3-dimension-al | 1 |
| 538 | the-medical | 1 |
| 539 | prenosological | 1 |
| 540 | 6-deoxy-d-glucal | 1 |
| 541 | jeotgal | 1 |
| 542 | close-to-optimal | 1 |
| 543 | 4-hydroperoxy-2-nonenal | 1 |
| 544 | hospital/regional | 1 |
| 545 | post-trascriptional | 1 |
| 546 | thermonuetral | 1 |
| 547 | 350mg/dl | 1 |
| 548 | arm-level | 5 |
| 549 | 0.9gl | 1 |
| 550 | atmospheric/soil | 1 |
| 551 | ferrell | 1 |
| 552 | 0.6-1mg/ml | 1 |
| 553 | 500ng/ml | 3 |
| 554 | 11pg/ml | 1 |
| 555 | 32pg/ml | 1 |
| 556 | 9.3pg/ml | 1 |
| 557 | 142μg/ml | 1 |
| 558 | 31.25μg/ml | 1 |
| 559 | 11-bromoundecan-1-ol | 1 |
| 560 | postprotocol | 4 |
| 561 | 3-mercaptohexanol | 1 |
| 562 | 4-bromo-2-methoxyphenol | 1 |
| 563 | eucosterol | 1 |
| 564 | 8.2±1.7j/m | 1 |
| 565 | 6.3kj/m | 1 |
| 566 | 22.9kj/m | 1 |
| 567 | 20.6ml/min/1.73m | 1 |
| 568 | 8.00am | 1 |
| 569 | 9:00am | 2 |
| 570 | chinnallapuram | 1 |
| 571 | ufr-mdm | 2 |
| 572 | jim | 3 |
| 573 | 31,000/mm | 1 |
| 574 | 6,600/mm | 1 |
| 575 | 0.80mm | 1 |
| 576 | 730nm | 1 |
| 577 | 690nm | 1 |
| 578 | youtube.com | 1 |
| 579 | www.cri-net.com | 1 |
| 580 | subbloom | 1 |
| 581 | 15rm | 2 |
| 582 | pre-delirium | 2 |
| 583 | sesuvium | 1 |
| 584 | mid-duodenum | 1 |
| 585 | 10-50μm | 1 |
| 586 | 0.35-2.04μm | 1 |
| 587 | o-alkynyl-n | 1 |
| 588 | half-scan | 2 |
| 589 | adcmedian | 4 |
| 590 | yang-meridian | 1 |
| 591 | yuanlijian | 1 |
| 592 | campanian-maastrichtian | 1 |
| 593 | hexian | 1 |
| 594 | 2,2-dimethyl-1,3-diaminopropan | 1 |
| 595 | lankaran | 1 |
| 596 | cran | 1 |
| 597 | n-bn | 1 |
| 598 | blue/green | 2 |
| 599 | nigerien | 1 |
| 600 | maljen | 1 |
| 601 | chloromethylmethoxypsoralen | 1 |
| 602 | grimmen | 1 |
| 603 | sogn | 1 |
| 604 | δmyoglobin | 1 |
| 605 | holo-protein | 1 |
| 606 | power-from-within | 1 |
| 607 | preproenkephalin | 1 |
| 608 | 80/min | 4 |
| 609 | -1°c/min | 1 |
| 610 | 24min | 1 |
| 611 | parthenin | 1 |
| 612 | pre-qin | 2 |
| 613 | 7-hydroxy-4-methylcoumarin | 1 |
| 614 | prenitroglycerin | 2 |
| 615 | pro-tk-subtilisin | 1 |
| 616 | ulcer/erosion | 1 |
| 617 | pre-infusion | 13 |
| 618 | pre-occlusion | 4 |
| 619 | conciliation | 1 |
| 620 | antiinitiation | 1 |
| 621 | over-regulation | 1 |
| 622 | self-preoccupation | 1 |
| 623 | intraoperation | 14 |
| 624 | preoperation | 24 |
| 625 | pre-immigration | 1 |
| 626 | end-expiration | 15 |
| 627 | thermo-sensitisation | 2 |
| 628 | baseline/randomization | 1 |
| 629 | rerevascularization | 1 |
| 630 | subpasteurization | 1 |
| 631 | preinfection | 8 |
| 632 | diagnosis-injection | 1 |
| 633 | post-first-injection | 1 |
| 634 | hiv-acquisition | 1 |
| 635 | pre-transition | 5 |
| 636 | sleep/attention | 1 |
| 637 | pre-intervention | 334 |
| 638 | pre-ingestion | 9 |
| 639 | preingestion | 8 |
| 640 | sopungsunkiwon | 1 |
| 641 | luzon | 3 |
| 642 | mn3sn | 1 |
| 643 | discharge-bun | 1 |
| 644 | cuso4•5h2o | 1 |
| 645 | merck-medco | 1 |
| 646 | aidsinfo | 1 |
| 647 | -chloro | 1 |
| 648 | lappro | 1 |
| 649 | fish-miso | 1 |
| 650 | motuo | 1 |
| 651 | short-gap | 1 |
| 652 | dbgap | 1 |
| 653 | pre-clamp | 5 |
| 654 | 10np | 1 |
| 655 | pre-lbnp | 5 |
| 656 | gainp | 1 |
| 657 | naprp | 1 |
| 658 | baseline/follow-up | 3 |
| 659 | il-27r | 1 |
| 660 | el-aghwar | 2 |
| 661 | scbr | 5 |
| 662 | pretreatmer | 1 |
| 663 | cellminer | 5 |
| 664 | metzner | 1 |
| 665 | 1-copper | 1 |
| 666 | radio-meter | 1 |
| 667 | higher-titer | 1 |
| 668 | 5p15.2pter | 1 |
| 669 | 8pter | 1 |
| 670 | 17qter | 1 |
| 671 | hrp/rhr | 2 |
| 672 | preoxygenator | 1 |
| 673 | 218.3ucarr | 1 |
| 674 | kasr | 6 |
| 675 | aatsr | 3 |
| 676 | epikur | 1 |
| 677 | nawarangapur | 1 |
| 678 | doddaballapur | 1 |
| 679 | -6.04°/s | 1 |
| 680 | -5.68°/s | 1 |
| 681 | metformin/sulfonylureas | 1 |
| 682 | gynecomastias | 1 |
| 683 | pikas | 1 |
| 684 | whccs | 1 |
| 685 | providers/clinics | 1 |
| 686 | core-foods | 1 |
| 687 | 1966-onwards | 1 |
| 688 | pre-apprentices | 1 |
| 689 | arylsulfonamides | 1 |
| 690 | 2-chloronicotinaldehydes | 1 |
| 691 | 681studies | 1 |
| 692 | small-arteries | 1 |
| 693 | 3,4-diaryl-2,5-dihydrothiophenes | 2 |
| 694 | 2-ethynylanilines | 1 |
| 695 | caprines | 1 |
| 696 | 3-benzoylpyridazines | 1 |
| 697 | 1,4-enediones | 1 |
| 698 | dyspnoes | 1 |
| 699 | chares | 3 |
| 700 | high-temperatures | 4 |
| 701 | trois-rivières | 1 |
| 702 | cross-purposes | 1 |
| 703 | trans-2-aroyl-3-aryl-cyclopropane-1,1-dicarboxylates | 1 |
| 704 | δes | 6 |
| 705 | 14.2kgs | 1 |
| 706 | pardis | 1 |
| 707 | mononitrotetrakis | 1 |
| 708 | in-stent-restenosis | 1 |
| 709 | pseudokeratosis | 1 |
| 710 | thielaviopsis | 2 |
| 711 | peridiverticulitis | 1 |
| 712 | trackvis | 1 |
| 713 | small-trials | 1 |
| 714 | doctors/hospitals | 1 |
| 715 | 2-ethynylbiaryls | 1 |
| 716 | oncoantigens | 1 |
| 717 | mid-tens | 1 |
| 718 | torremolinos | 1 |
| 719 | non-mtrps | 1 |
| 720 | viups | 1 |
| 721 | micro-ulcers | 1 |
| 722 | 6th-graders | 1 |
| 723 | photocopiers | 2 |
| 724 | nonhealers | 1 |
| 725 | workshop-floors | 1 |
| 726 | ldl-precursors | 1 |
| 727 | bush-doctors | 1 |
| 728 | hif-inhibitors | 1 |
| 729 | over-stress | 1 |
| 730 | 1997-2005.subjects | 1 |
| 731 | uti-infants | 1 |
| 732 | preruminants | 1 |
| 733 | hospitalizedpatients | 1 |
| 734 | symptoms/events | 1 |
| 735 | gynecologists/urogynecologists | 1 |
| 736 | check-lists | 2 |
| 737 | agelanthus | 2 |
| 738 | near-conscious | 2 |
| 739 | arterio-to-mixed-venous | 1 |
| 740 | 0.59±0.38days | 1 |
| 741 | gαs | 3 |
| 742 | barasat | 3 |
| 743 | pre-sbt | 3 |
| 744 | speech-act | 1 |
| 745 | regshospitalet | 1 |
| 746 | vo2net | 1 |
| 747 | errant | 4 |
| 748 | bar/restaurant | 8 |
| 749 | dunavant | 1 |
| 750 | advancent | 1 |
| 751 | p73-deficient | 1 |
| 752 | £3002/patient | 1 |
| 753 | assessment-to-assessment | 2 |
| 754 | preassessment | 13 |
| 755 | eses-treatment | 1 |
| 756 | midtreatment | 26 |
| 757 | baseline-posttreatment | 1 |
| 758 | pre-to-posttreatment | 1 |
| 759 | remitted-recurrent | 1 |
| 760 | 1946-present | 1 |
| 761 | codont | 1 |
| 762 | nicotine/cotinine/3-oh-cot | 1 |
| 763 | tmz/rt | 1 |
| 764 | tpf-ccrt | 2 |
| 765 | postrest | 4 |
| 766 | serologist | 1 |
| 767 | freelist | 4 |
| 768 | baseline-to-post | 2 |
| 769 | m-pst | 4 |
| 770 | bott | 1 |
| 771 | turn-out | 1 |
| 772 | actn3-knockout | 1 |
| 773 | mongu | 1 |
| 774 | mogadishu | 1 |
| 775 | okpanku | 1 |
| 776 | bolu | 1 |
| 777 | wuzhou | 1 |
| 778 | 140kv | 1 |
| 779 | pre-pbmv | 2 |
| 780 | lvov | 1 |
| 781 | pre-bpv | 1 |
| 782 | lmax | 30 |
| 783 | arbatax | 1 |
| 784 | ozonytronx | 1 |
| 785 | 2.0μg/day | 1 |
| 786 | tuesday | 7 |
| 787 | malay-balay | 1 |
| 788 | foreplay | 2 |
| 789 | midpregnancy | 29 |
| 790 | ego-resiliency | 3 |
| 791 | €8000/qaly | 1 |
| 792 | €3011/qaly | 1 |
| 793 | £3855/qaly | 1 |
| 794 | post-immediately | 1 |
| 795 | bucally | 2 |
| 796 | methoxy-poly | 1 |
| 797 | regional/tertiary | 1 |
| 798 | service-entry | 1 |
| 799 | haughty | 1 |
| 800 | isoosmolality | 1 |
| 801 | log-normality | 1 |
| 802 | dose-linearity | 2 |
| 803 | unpopularity | 1 |
| 804 | mp2/aug-cc-pvdz | 1 |
| 805 | 2.5-hz | 1 |
| 806 | görlitz | 1 |
| 807 | auschwitz | 2 |
| 808 | c₄₀₋₆₄ | 1 |
| 809 | 1.80å | 1 |
| 810 | 8013€ | 1 |
| 811 | acandí | 1 |
| 812 | webthal® | 1 |
| 813 | 45°-60° | 1 |
| 814 | 214° | 1 |
| 815 | α-trifluoromethyl-α | 1 |
| 816 | t5· | 1 |
| 817 | 2θ | 2 |